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FOREWORD
Two challenges stand out as we contemplate the 
future of health services in the United Kingdom.  
The first is the state of the public finances and 
therefore the pressure in real terms on health 
services funding. The second is the recurring and 
vexing problem of health inequalities. The state of 
health inequalities in Britain has been commented on 
by many, but we have seen precious little real change 
in the disproportionate burden of early death and 
illness among the most disadvantaged and indeed 
across the whole health gradient in recent years.  
In the light of both these problems, this report makes 
refreshing reading. The authors present an argument 
that, in a nutshell, promises to make considerable 
savings for the health services, produce long run 
health benefits and is a mechanism for changing the 
differences in health outcomes across social groups. 
The idea is, of course, simplicity itself: improving 
the rates of the initiation and the continuation of 
breastfeeding. Old fashioned public health, one 
might suppose; but breastfeeding as this report 
demonstrates, has profoundly beneficial effects on 
the lives of infants, children and their mothers, and  
is an arena where the interests of mothers and 
babies align with those of the health service and 
wider society.
The argument that the authors develop is that there 
are large costs to the health service of treating 
diseases that are associated with not breastfeeding. 
The approach is conservative. They press into service 
what they define as the highest quality evidence 
and they focus on diseases where the most 
confidence can be placed in the data. They show 
that the savings associated with not having to treat 
gastrointestinal and lower respiratory tract infections, 
acute otitis media and necrotising enterocolitis in 
infants would yield considerable cost savings. When 
a broader view is taken, and cases of breast cancer, 
Sudden Infant Death Syndrome, poor cognitive 
development and early years’ obesity are included, 
additional cost savings accrue correspondingly.
 
The authors use a variety of economic techniques 
and a very careful review and appraisal of the 
evidence to draw their conclusions. They confine  
their analyses to health service costs. They do not 
consider broader costs to society. Nor do they deal in 
detail with the many other health problems that have 
been linked over the years to not breastfeeding, such 
as type 2 diabetes, cardiovascular disease, asthma 
and adult obesity. They do, however, note that if 
costs beyond the health sector were to be included 
and if these other conditions could be built into 
the analyses, then the cost savings would be very 
significant indeed.  
Using one local area as the basis for illustrating the 
costs of taking a proactive approach to addressing  
low breastfeeding rates, they are able to show  
what the costs of such an intervention would be  
and how quickly the savings would appear on the 
balance sheet.
This is an important report in several ways. It is 
important scientifically – the methods used are at 
once rigorous and novel. It is important practically –  
it shows what can be done to make matters better. 
And it is important for policy – it shows in stark relief 
what the nature of the problem is but also presents 
the potential solutions.
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acute otitis media (AOM) middle ear infection
any breastfeeding Infant receives some breastmilk: either only breastmilk (see exclusive breastfeeding) or 
breastmilk and other substances (see mixed feeding, partial breastfeeding, complementary 
feeding). Any breastfeeding is used to describe the feeding of a group of infants who received 
different amounts of breastmilk, or when the amount of breastmilk they were fed is not known.
artificial feeding Infant is fed only on a breastmilk substitute (World Health Organization, 2003). See breastmilk 
substitutes; formula.
Baby Friendly Awards The Baby Friendly Initiative of UNICEF UK accredits, through a staged assessment process, 
maternity and community facilities that adopt internationally recognised standards of best 
practice in the care of mothers and babies.
Baby Friendly Initiative Worldwide programme of the World Health Organization and UNICEF to encourage maternity 
hospitals to implement the 10 Steps to Successful Breastfeeding and to practise in accordance 
with the International Code of Marketing of Breast-milk Substitutes.
base case models Models that normally include the best assumptions and data estimates in the analysis.
breastmilk substitutes Any food being marketed or otherwise represented as a partial or total replacement for 
breastmilk, whether or not it is suitable for that purpose (World Health Organization, 2003).
lower respiratory bronchiolitis or pneumonia
tract infection (LRTI) 
cardiovascular disease Disease of the heart and blood vessels usually manifesting as high blood pressure, heart 
attack and stroke
chronological age Time since the infant’s birth (Engle and American Academy of Pediatrics, 2004). See also 
corrected age; gestational age; postmenstrual age. 
coeliac disease Inflammation of the gut cause by an immune reaction to gluten (a wheat protein)
comparator Circumstance with which the subject intervention is compared.
complementary feeding Child receives both breastmilk and solid (semi-solid or soft) foods. It is not recommended to 
provide any solid, semi-solid or soft foods to children less than six months of age (World  
Health Organization, 2003). See any breastfeeding; exclusive breastfeeding, mixed feeding; 
partial breastfeeding.
corrected age Chronological age reduced by the number of weeks born before 40 weeks of gestation. The 
term applies to children up to 3 years old who were born preterm (Engle and American Academy 
of Pediatrics, 2004). See chronological age; preterm birth.
cost-of-illness study Specific type of analysis that aims to measure the economic burden of a disease or diseases. 
Such studies can help to estimate the potential savings if a disease were to be prevented or 
eradicated.
enteral feeding Administration of any feed into the gastrointestinal tract.
exclusive breastfeeding Infant receives only breastmilk (including breastmilk that has been expressed or from a wet 
nurse) and nothing else, except for medicines, vitamins and minerals, oral rehydration salts 
(World Health Organization, 2003).
formula Artificial milks for babies made out of a variety of products including sugar, animal milks, soya 
beans, and vegetable oils. They are usually in powder form to mix with water (World Health 
Organization, 2003). Currently, in Europe, formula is modified from cow’s or soya milk and 
manufactured according to compositional standards prescribed in the European Directive or 
Codex Alimentarius. See preterm formula. 
fortified feeds, fortifiers Addition of protein, vitamins and minerals to breastmilk with the aim of meeting preterm infants’ 
specific nutritional needs.
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gastroenteritis,  diarrhoea and vomiting attributable to infection
gastrointestinal infection (GI) 
gavage feeds Introduction of food into the stomach by means of a tube inserted through the mouth (orogastric) 
or the nose (nasogastric).
gestational age Time between the first day of the mother’s last menstrual period and the infant’s birth (Engle and 
American Academy of Pediatrics, 2004). See also chronological age; postmenstrual age.
incidence Proportion of new cases of a condition occurring within a certain period. For example, the 
number of mothers who initiate breastfeeding. 
industrialised setting Country or region, generally located in the northern or western hemisphere, whose economy 
is based on industry (Natural Resources Defence Council). This level of economic development 
usually translates into a high income per capita and a high Human Development Index (HDI) for 
populations within that country or region.
intention to treat Outcome is analysed by participants’ original treatment allocation, whether or not they 
completed the study.
International Code of Marketing  Code restricting the marketing of breast-milk substitutes to the public and health professionals. 
of Breast-milk Substitutes  The Code was ratified by the World Health Assembly in 1981, and incorporates subsequent 
World Health Assembly resolutions. It has been wholly or partly implemented as national law in 
several countries. 
low birth-weight infant Infant with birth weight less than 2,500g.
milk bank Service that screens donors, collects, processes, stores and distributes donated breastmilk.
mixed feeding Infant receives both breastmilk and any other food or liquid including water, non-human milk 
and formula before 6 months of age (World Health Organization, 2003). See any breastfeeding; 
complementary feeding; exclusive breastfeeding; partial breastfeeding.
multiples Infants who are the product of triplet, quadruplet (or more) pregnancy.
mx value mx is the central rate of mortality, defined as the number of deaths at age x last birthday in the 
three year period to which the Interim Life Table relates divided by the average population at 
that age over the same period. Source: Government Actuary’s Department, available at:  
http://bit.ly/SY4nc5 (accessed 28 May 2012).
nasogastric feeding Administration of feeds into the stomach via a tube passed through the nose.
necrotising enterocolotis (NEC) serious inflammatory condition of the gut in newborn babies, usually those  
prematurely born
neonatal sepsis infection of the newborn caused by bacteria in the bloodstream
oral feeding Administration of any feed into the mouth. 
orogastric feeds Administration of feeds into the stomach via a tube passed through the mouth.
parenteral feeding Intravenous provision of fluid and nutrients when infants are unable to receive their whole dietary 
requirements enterally.
parous Woman who has given birth to one or more children
partial breastfeeding One of several terms for breastfeeding that is not exclusive. See any breastfeeding; 
complementary feeding; exclusive breastfeeding; mixed feeding).
population attributable Used for exposures that result in an increased risk of disease (for example, smoking) rather than 
fractions (PAF)  a protective effect (for example, breastfeeding). See also preventive fractions.
postmenstrual age Gestational age plus chronological age (Engle and American Academy of Pediatrics, 2004)  
See also chronological age; gestational age.
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post-term birth Birth occurring after 42 completed weeks of gestational age.
prevalence The proportion of cases of a condition among the population at risk. For example, the proportion 
of mothers who are breastfeeding at a particular point in time.
preterm birth Birth occurring before 37 weeks of gestational age.
preterm formula Modified cow’s or soy milk manufactured to Codex Alimentarius standards and endeavouring to 
meet the specific nutritional requirements of preterm infants.
preterm infant Infant born before 37 weeks of gestational age.
preventive fractions (PF) Preventive fractions allow incorporation of exposures, such as breastfeeding, that have several 
categories and a protective effect. See population attributable fractions. 
primiparous Woman who has given birth to only one child
QALYs Acronym for Quality Adjusted Life Year. QALY is a measure of health outcome that takes into 
account both quantity and quality of life lived. One QALY is said to be gained if a medical or 
health-care intervention leads an individual to live one extra year in full health.
SCBU Special Care Baby Unit
sensitivity Technique that handles several types of uncertainty associated with economic analysis by 
determining which input parameters are the key drivers of an economic model’s conclusions.
stable infant Infant who has adapted successfully to extrauterine life and does not require continuous medical 
monitoring or supportive intervention.
term birth Birth occurring between 37 and 42 completed weeks of gestational age.
very low birth-weight infant Infant with birth weight less than 1,500g.
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 Low breastfeeding rates in the UK lead to an 
increased incidence of illness that has a significant 
cost to the health service. 
 Investment in effective services to increase and 
sustain breastfeeding rates is likely to provide a return 
within a few years, possibly as little as one year. 
 Investing in supporting women to breastfeed will 
improve the quality of life for women through the 
reduction in incidence of breast cancer; and for 
children through reducing acute and chronic diseases. 
 Research into the extent of the burden of disease 
associated with low breastfeeding rates is hampered 
by data collection methods; this can be addressed by 
investment in good quality research.
KEY MESSAGES
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EXECUTIVE SUMMARY
UNICEF UK commissioned this report to better 
understand the potential contribution that increasing 
breastfeeding rates would make to preventing 
disease and saving resources. This report shows 
that investment to increase and sustain 
breastfeeding rates will provide a rapid financial 
return on investment. 
The UNICEF UK Baby Friendly Initiative was 
introduced 16 years ago to bring UK health services 
up to a minimum standard in their support of 
breastfeeding. At that time, the UK had one of the 
world’s most entrenched bottle-feeding cultures 
and consequently one of the lowest breastfeeding 
rates. While there have been increases in the 
proportion of mothers initiating breastfeeding, 
discontinuation of breastfeeding in the days and 
weeks after birth continues to be a major concern. 
Low breastfeeding rates in the UK lead to 
an increased incidence of illness that has a 
significant cost to the health service. 
The strong evidence of the health risks associated 
with not breastfeeding makes this a major public 
health issue that requires investment and an 
organised and informed response. Investment in 
supporting women to breastfeed will improve the 
quality of life for women and for children through 
reducing acute and chronic diseases.  
We know that the overwhelming majority of mothers 
who breastfeed stop before they want to, and so 
UNICEF UK is calling for leadership and investment in 
order to remove the barriers that prevent women from 
successfully breastfeeding for as long as they choose.
This study aims to fill a gap 
of rigorous research relating 
specifically to the UK that 
could answer whether 
increasing the prevalence of 
breastfeeding will translate 
into significant cost savings.
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Aims
Increased awareness of the health risks associated 
with not breastfeeding has brought about a drive in 
recent years to improve breastfeeding support and 
increase breastfeeding prevalence in the UK, where 
breastfeeding rates have been among the lowest 
in the world for many decades. Governments have 
encouraged improvement of breastfeeding support 
by funding maternity hospitals and community 
settings to engage in a number of national and  
local strategies including the UNICEF UK Baby 
Friendly Initiative. 
There is an underlying policy assumption that 
increasing the prevalence of breastfeeding will 
translate into significant cost savings for the health-
care system. However, there is still a lack of rigorous 
research relating to the UK. This study aims to fill 
that gap. 
Methods
A series of reviews identified studies that could 
quantify 
a) the risk of increased disease linked to not 
breastfeeding and 
b) the cost of illness related to low breastfeeding 
rates in the UK. 
For each disease or condition, realistic, achievable 
scenarios for potential increases in breastfeeding 
rates were developed. To illustrate how the findings 
could be used to inform policy and practice, the study 
examines the costs that could be saved in an area of 
the UK that has a clearly defined, evidence based, 
infant feeding strategy.
Because it is seldom possible to conduct 
randomised controlled trials in this field, analysis 
relies mainly on observational data. It is therefore 
important to recognise and control for confounding 
variables – such as socio-economic background, 
or other systematic differences between women 
who breastfeed and those who do not – to avoid 
overestimating the scale of the differences between 
groups. However, as women in the UK and other 
developed countries often breastfeed for a short 
time, or mix feeding methods, few studies have 
been able to examine the impact of breastfeeding 
exclusively for the first six months of life. This 
may result in differences between groups being 
underestimated. 
In this study we have adopted a methodological 
approach that is both systematic and transparent, 
taking care not to overestimate or underestimate 
the burden of disease or the costs resulting from not 
breastfeeding. To avoid the risk of overestimation 
of costs, however, we consistently erred on the 
side of conservative assumptions when making 
methodological decisions.
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Our quantitative economic models are based on 
best quality evidence, relevant to the UK, where 
we could provide a reliable estimate of effect size, 
and therefore the economic impact. As so many 
other outcomes do not have evidence in the form 
required for economic modelling and as we have 
only included costs to the health sector, these 
estimates are likely to be a minimum estimate of the 
economic consequences of the current low rates of 
breastfeeding in the UK. The true scale  
of the impact of breastfeeding is likely to be  
much greater. 
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Results
Four categories of reviews and studies  
were identified:
Category 1
A total of 25 systematic reviews and UK studies  
provided robust evidence for economic analysis. We 
developed quantitative models for five outcomes: 
•	 four acute conditions in infants: gastrointestinal 
disease, respiratory disease, otitis media, and 
necrotising enterocolitis (NEC) 
•	 breast cancer in mothers. 
 
Quantitative models found that:
Assuming a moderate increase in breastfeeding 
rates, if 45% of women exclusively breastfed for four 
months, and if 75% of babies in neonatal units were 
breastfed at discharge, every year there could be an 
estimated:
•	 3,285 fewer gastrointestinal infection-related 
hospital admissions and 10,637 fewer GP 
consultations, with over £3.6 million saved in 
treatment costs annually 
•	 5,916 fewer lower respiratory tract infection-
related hospital admissions and 22,248 fewer 
GP consultations, with around £6.7 million 
saved in treatment costs annually 
•	 21,045 fewer acute otitis media (AOM) related 
GP consultations, with over £750,000 saved in 
treatment costs annually 
•	 361 fewer cases of NEC, with over £6 million 
saved in treatment costs annually.
In total, over £17 million could be gained  
annually by avoiding the costs of treating four 
acute diseases in infants. Increasing breastfeeding 
prevalence further would result in even greater  
cost savings.
 
 
If half those mothers who currently do not 
breastfeed were to breastfeed for up to 18 months 
in their lifetime, for each annual cohort of around 
313,000 first-time mothers there could be:
•	 865 fewer breast cancer cases 
•	 with cost savings to the health service of over 
£21 million 
•	 512 breast cancer-related quality adjusted life 
years (QALYs) would be gained, equating to a 
value of over £10 million. 
This could result in an incremental benefit of  
more than £31 million, over the lifetime of each 
annual cohort of first-time mothers.
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 Category 2
Evidence on three outcomes was identified where 
limitations of the current evidence base means 
that the scale and scope of the economic impact 
was difficult to measure with precision. For these, 
the evidence was adequate to provide narrative 
analyses to indicate the scale and scope of the costs 
to the health service and beyond. The outcomes 
examined were: cognitive outcomes, early years 
obesity, and Sudden Infant Death Syndrome (SIDS) 
Narrative analyses found that: 
•	 if just 1% of those who currently “never 
breastfed” were to initiate breastfeeding, it 
could be associated with a small increase in 
average IQ that in turn could result in over £278 
million gains in economic productivity over the 
lifetime of each annual birth cohort. 
•	 a very modest increase in the rates of exclusive 
breastfeeding could be associated with the 
avoidance of at least three cases of SIDS 
annually, averting the profound consequences 
for families and avoiding an annual monetary 
loss of around £4.7 million and a loss of £1.3 
million annually in QALYs. 
•	 increasing breastfeeding rates to a level 
compatible with reducing the rates of early 
years obesity by as little as 5%, would result 
in reducing annual health-care expenditures by 
more than £1.6 million.
The nature of these conditions, and the limitations of 
the current evidence base, mean that the scale and 
scope of the economic impact is difficult to measure 
with precision. It is evident that it is likely to be very 
wide ranging and significant. The work on these 
topics, together with the other chronic diseases 
identified, informs an important research agenda.
Category 3
We identified a further eight outcomes where it is 
plausible that the outcome is related to infant feeding, 
but where the strength of evidence, or where the 
way in which outcomes or infant feeding had been 
measured, is inadequate to inform an economic 
analysis. These include chronic diseases in both the 
mother and infant that are very costly to the health 
service. This list demonstrates the potential extent of 
the economic consequences of not breastfeeding in 
the UK, which is likely to be much greater than the 
quantitative models we have been able to develop. 
It also acts as a research agenda for future studies of 
the costs of disease and developmental outcomes. 
The outcomes identified were: 
•	 Ovarian cancer and Type 2 diabetes in  
the mother
•	 Asthma, diabetes, leukaemia, coeliac disease, 
cardiovascular disease, and sepsis in the child. 
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Category 4 
A further 45 outcomes were identified where there is 
some evidence of association with not breastfeeding. 
These form an agenda for future research, therefore 
these outcomes are not shown in Figure 1 
CATEGORY 3
Long list of eight conditions:
ovarian cancer (maternal), diabetes (maternal and child),
asthma, leukaemia, coeliac disease, 
cardiovascular disease, sepsis (affecting child)
CATEGORY 2
Narrative economic
analysis of three conditions:
obesity, cognitive outcomes,
Sudden Infant Death Syndrome (affecting child)
CATEGORY 1
Economic models
of five diseases:
breast cancer (maternal), 
gastrointestinal infection, 
necrotising enterocolitis,
lower respiratory tract infection,
acute otitis media (affecting child),
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Figure 1 
Diagrammatic representation of the costs 
resulting from disease and developmental deficit 
resulting from low rates of breastfeeding in the UK 
(illustrative, not representative). Conceptually the 
costs estimated in section 4 are likely to be a small 
sub-set of the real NHS costs associated with low 
breastfeeding rates.
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Investing in enabling women  
to breastfeed
Because breastfeeding rates in the UK have been 
so low for so long, health service and community 
support for breastfeeding is not consistent. To break 
the cycle of linked factors that make breastfeeding 
difficult for women in the UK (illustrated below, Figure 
2), changes are needed to address the societal, family 
and health service barriers to breastfeeding. 
 
From a health service perspective, increasing 
breastfeeding rates will require resources to be 
invested in services. To understand the full economic 
picture, the cost needed for support services should 
be set against the costs saved from preventing 
disease. Using one English region as an example, 
we illustrated the cost of implementing an evidence-
based, multifaceted programme that would build on 
priority national recommendations. Within any UK 
locality of similar size, population base, and current 
breastfeeding rates, such a programme would cost 
around £446,300 in its first year with a recurring 
annual cost of around £329,300. 
The time taken to realise the investment will depend 
on the rate at which breastfeeding initiation, duration 
and exclusivity increase, which in turn will depend 
both on factors in the local population and on the 
extent and quality of services to support breastfeeding 
women. The diseases studied here have shown a 
dose-response effect that means that even a small 
increase is likely to result in some savings.
Our estimates, based on our analyses, suggest that 
the time required to show a positive return on 
investment is likely to be within a few years and 
possibly as little as one year.
Figure 2: The linked factors that exist when women 
are not enabled to breastfeed for as long as they wish, 
resulting in avoidable burden of disease and costs to 
the health service and wider economy. (Derived from 
findings of studies, including Dyson et al, 2006.)
Changes to address the 
societal, family and 
health service barriers to 
breastfeeding are needed to 
break the cycle of linked factors 
that make breastfeeding 
difficult for women in the UK.
Low
breastfeeding
rates
Societal
barriers continue
Normative
use of formula
High rates
of breastfeeding
problems
Lack of
support and
services to enable
women to
 breastfeed
Lack of 
knowledge
and experience of
breastfeeding –
health professionals,
academics, wider
society
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Harrow case study
Harrow Community Services and Northwick Park 
Hospital are examples of where joint investment in 
support services for women has translated into higher 
breastfeeding rates and reduced illness in babies. Work 
towards the UNICEF UK Baby Friendly Standards started 
in 2005, when the breastfeeding initiation rate was 
67% and only 33% of mothers were still exclusively 
breastfeeding at 6–8 weeks. Multidisciplinary training 
was rolled out for midwives, health visitors and GPs 
across the acute trust and community services, so that 
women experienced a joined-up consistent level of care. 
A widespread network of trained peer supporters has 
been set up who work with mothers in hospital and in 
the community and run breastfeeding support groups 
on every weekday. Harrow now has a breastfeeding 
helpline, website, Facebook page and Twitter site, all run 
by peer supporters.
In 2012, 90% of mothers are initiating breastfeeding and 
50% of mothers exclusively breastfeed at 6–8 weeks. 
Along with some other London boroughs, Harrow is 
seeing a reduction of children less than 1-year-old being
admitted to hospital with gastronenteritis, and these
rates are 16% lower than the current UK average for 
health authorities. Breastfeeding is becoming the normal 
way to feed babies in Harrow.
Conclusions and recommendations
Enabling women to breastfeed for as long as they 
choose to is a health issue where the interests of the 
mother, baby and the health services all align. This 
study shows that the more common breastfeeding 
becomes, particularly exclusive and continued 
breastfeeding, the higher the cost savings to the 
health service will be. Despite the conservative 
approach we have taken, it should reassure 
policymakers, service planners and commissioners 
that investment in effective services to support 
women to breastfeed is likely to produce a return on 
investment within a few years, possibly as little as 
one year.
Investing in public health interventions, particularly 
at a time when funds are scarce, is challenging, as 
many of the potential financial savings accrue in the 
distant future. However, as shown in this report, 
many of the potential savings from breastfeeding 
support are likely to be realised over a much 
shorter time horizon. At a time when healthcare 
investments need to show a near-term return on 
investment, this is an important consideration.
Research is needed to extend our knowledge 
of the impact of infant feeding on health. This 
would improve the modelling and analyses we 
have undertaken. Most importantly, long-term 
prospective cohort studies should be established 
specifically to examine these issues. These 
should use accurate measurement of different 
infant feeding methods. We identified a priority list 
of eight further, mainly chronic, diseases where 
data exist, but not yet in a form that permits 
economic modelling. Until adequate data on 
these conditions are available, the potential for 
breastfeeding to reduce the distress and expense 
associated with chronic diseases cannot be  
fully measured. 
There are social, educational, family and wider 
economic costs to low breastfeeding rates that are 
not considered in this report. However the findings 
signal a need for society to debate infant feeding 
more widely; its economic consequences, its role 
in child health, child development, maternal health, 
family life and relationships.
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1  BACKGROUND AND CONTEXT
Increased awareness of the health risks associated 
with not breastfeeding has brought about a drive in 
recent years to improve breastfeeding support and 
increase breastfeeding prevalence rates in the UK. 
Targets have been set and financial support offered 
to UK health services to implement the Baby Friendly 
Initiative and other strategies.
There is an underlying policy assumption that 
increasing the prevalence of breastfeeding will 
translate into significant cost savings for the health-
care system. However, there is still a lack of rigorous 
evidence relating to the health services within the 
UK. The purpose of this study is to fill this gap by 
determining if there would be any savings, and if so, 
how much and over what time span.
The economic impact of infant feeding is extensive 
and multi-faceted. Studies in the USA, Australia, and 
the Netherlands have shown that large-scale savings 
to their national economies would result from raising 
breastfeeding rates. The costs of not breastfeeding 
include health service costs such as treating a range 
of related diseases affecting mothers and children, 
and costs to families such as the cost of purchasing 
infant formula (Bartick and Reinhold, 2010; Weimer, 
2001; Smith et al, 2002; Drane, 1997; Ball and 
Wright, 1999; Buchner et al, 2007). Breastfeeding 
women make a substantive, direct and positive 
contribution to the national economy through the 
production and supply of breastmilk (Smith, 1999). 
In countries with low breastfeeding prevalence, 
realising the savings that would result from 
increasing breastfeeding rates will require an 
investment in promotion and support programmes to 
enable more women to breastfeed. When examining 
the costs to the health service, the balance between 
savings and costs need to be considered. 
Differences in social, political and economic contexts 
between the UK and the countries in which previous 
studies have been conducted raise questions about 
the scale of expected cost savings in the UK. For 
example, rates of exclusive breastfeeding and the 
duration of any breastfeeding have been very low for 
many years (Bolling et al, 2007), and women report  
 
a range of problems with breastfeeding, including 
problems of breastfeeding in public, that make 
continuing to breastfeed particularly challenging 
in the UK (Dyson et al, 2010a; Lee, 2007). It is 
especially important for policymakers to have access 
to UK data based on up-to-date information to 
inform service planning, commissioning and policy 
decisions. 
This study addresses the question: what is the 
potential contribution of increasing breastfeeding rates 
to preventing disease and saving resources in the UK? 
1.1  Why infant feeding matters
There is good quality evidence quantifying the short-
term and long-term health risks of not breastfeeding 
for both infants and their mothers. Not breastfeeding 
has important adverse effects across all income 
bands. Breastfeeding provides complete food and 
nutrition by responding to the needs of the individual 
infant through the day and over time, and it provides 
active immunity to disease tailored to each baby’s 
individual circumstances (Hanson, 2004). Good 
quality studies of conditions such as gastroenteritis, 
respiratory disease, SIDS, and otitis media for 
infants, and breast cancer for mothers, have shown 
that all of these conditions are more prevalent when 
infants are not breastfed (Howie et al, 1990; Wilson 
et al, 1998; Ip et al, 2007; Horta et al, 2007; Quigley 
et al, 2007a; Collaborative Group on Hormonal 
Factors in Breast Cancer et al, 2002). Recent studies 
have shown an increased risk of poorer cognitive 
development and behavioural problems in children 
who were not breastfed (Heikkilä et al, 2011; Quigley 
et al, 2011; Kramer et al, 2008). 
There are inherent differences between breastmilk and 
the substitutes used to replace breastfeeding (such as 
infant formula, water, fruit juice or solid foods). 
•	 Infant formula marketed in the UK meets 
international nutritional standards but its 
composition differs substantially from 
breastmilk. Its ingredients vary between 
manufacturers, it does not confer immunity, 
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nor does it promote neurological development 
as breastmilk does (Michaelsen et al, 2009), it 
has no direct impact on maternal health, and it 
requires manufacturing, storage and delivery 
systems with inherent quality control problems 
(McNiel et al, 2010; European Food Safety 
Authority (EFSA) Scientific Panel on Biological 
Hazards, 2004).  
•	 The premature introduction of solid foods to 
the baby can result in health problems including 
increased respiratory infections (Wilson et 
al, 1998), and both fluids and solids displace 
breastmilk in the baby’s diet (Kramer and 
Kakuma, 2002). 
Recognising these inherent differences and the 
resultant impact of breastmilk substitutes on 
short and long-term health, international public 
health recommendations have been agreed. 
These state that, with the exception of specific 
health circumstances where breastfeeding is 
contra-indicated, infants in all settings should be 
exclusively breastfed until six months of age, and 
that breastfeeding should continue, along with 
appropriate solid foods and fluids, until at least two 
years of age (WHO, 2003). These recommendations 
have been endorsed by the UK health departments. 
1.2 Rates of breastfeeding and formula feeding
Around 81% of new mothers in the UK start to 
breastfeed (Information Centre for Health and Social 
Care, 2011). There has been a steady increase 
in this proportion in all four countries since 1990, 
when around 62% of women in the UK initiated 
breastfeeding (Hamlyn et al, 2002). It is likely that 
this trend is a consequence of increased public 
and professional awareness of the impact of 
infant feeding on health, and of public health policy 
developments in all four countries (UNICEF UK BFI, 
2001, Department of Health, 2007; National Institute 
for Health and Clinical Excellence, 2008 updated 
2011; Department of Health, 2009; The Scottish 
Government, 2011; Department of Health, 1995; 
Northern Ireland Breastfeeding Strategy Group, 
1999; SACN/RCPCH Expert Group on Growth 
Standards, 2007). 
However, the proportion of women still 
breastfeeding at six weeks after birth increased 
by only a few percentage points between 2000 
and 2005 – to just under 50% (Bolling et al, 2007). 
Rates of exclusive breastfeeding are much lower 
– only 45% of women reported that they were 
breastfeeding exclusively at one week after birth; 
fewer than 1% were still doing so at six months 
(Bolling et al, 2007). The rapid discontinuation of 
breastfeeding in the early days and weeks after 
birth, seen consistently 
since national surveys 
began in 1975, has only 
marginally improved to 
date, demonstrating 
that women who start 
to breastfeed often 
encounter problems, whether socio-cultural or clinical 
in nature, and stop. Ninety per cent of women who 
stop breastfeeding in the first six weeks report that 
they discontinue breastfeeding before they want to 
(Bolling et al, 2007). As a consequence, women can 
feel that they have failed their babies (Lee, 2007), 
and the great majority of babies in the UK are fed 
with formula in full or in part at some time during the 
first six months of life, and by five months of age, 
75% of babies in the UK receive no breastmilk at all.
1.3 Infant feeding and inequalities
The babies most likely to be breastfed are 
those from families living in relatively affluent 
circumstances and with well-educated parents, 
or families from minority ethnic backgrounds 
(Kelly and Watt, 2005; Bolling et al, 2007; Brown 
et al, 2010). Babies of parents from low-income 
backgrounds, who are young, white, with fewer 
educational qualifications and who were themselves 
formula fed, are least likely to be breastfed. This is 
an intergenerational problem: women are likely to 
follow the infant feeding patterns of their mothers. 
In some low-income communities, formula feeding 
is endemic and breastfeeding is rarely seen, making 
a fundamental contribution to inequalities in health 
(Nelson, 2000). Thus not being breastfed is both 
a consequence and a cause of social inequalities, 
since babies who are not breastfed are more likely 
to develop ill health. Promoting breastfeeding, 
90% of women who stop 
breastfeeding in the first 
six weeks report that they 
discontinue breastfeeding 
before they want to
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protecting families and health professionals from 
advertising about breastmilk substitutes, and 
supporting women to breastfeed, are among the 
most effective early years strategies intended to 
improve health and tackle inequalities (Field, 2010; 
Marmot, 2010; Wilson et al, 1998). This has been 
recognised internationally in the adoption of the 
International Code on the Marketing of Breast-milk 
substitutes (WHO, 1981), the development of a 
Global Strategy for Infant and Young Child Feeding 
(WHO, 2003), the adoption of an EU Blueprint for 
action on the protection, promotion and support for 
breastfeeding in Europe (EU Project on Promotion 
of Breastfeeding in Europe, 2008), and recently by 
the inclusion of breastfeeding in the Public Health 
Outcomes Framework for England (Department of 
Health, 2012).
1.4 Factors influencing infant feeding patterns  
in the UK
Breastfeeding rates in the UK fell sharply throughout 
the first half of the 20th century, from the virtually 
universal breastfeeding seen up to the late 19th 
century (Fildes, 1986) and reaching very low levels in 
the 1960s and 70s. The first national infant feeding 
survey conducted in England and Wales in 1975 
found that 51% of women started to breastfeed 
(Martin, 1978). The social changes that accompanied 
this decline mean that families today encounter 
numerous challenges if they consider breastfeeding. 
There is often an unsympathetic public attitude to 
breastfeeding outside of the home, an acceptance 
of formula feeding as a normal and safe way to 
feed babies, a lack of expertise and experience of 
breastfeeding among health service staff and, in 
many communities, a dearth of practical experience 
of breastfeeding among grandparents who might 
be expected to support and inform new parents 
about aspects of infant care (Renfrew, 2006; Dyson 
et al, 2010a; McMillan et al, 2009; Dykes, 2006). 
Breastfeeding is often the subject of contentious 
Victoria and Amelie
Victoria has both good and bad experiences of 
breastfeeding care when she had her baby Amelie in 
early 2012. “In the hospital, I had to push to be let to 
have skin to skin contact and to have assistance with 
feeding. The postnatal ward was very full and I had 
a C-section, so I had to buzz to get someone to lift 
Amelie so I could feed her: only to be told ‘Oh, she 
doesn’t need feeding’.”
“My daughter went from 8lb 
to 7lb 2oz in 5 days and led to 
me having significant worries 
about her weight for months 
to come and I nearly stopped 
breastfeeding due to the lack of 
assistance and advice.
“The locally run breastfeeding clinic had great support 
and advice but I found it difficult to access in the first 
few weeks due to having a C-section and not being 
mobile. However, I also had some amazing nursery 
nurses and midwives to help. It really was the luck of 
the draw.”
The locally run 
breastfeeding 
clinic had 
great support 
and advice
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discourse in both public and professional forums 
(Martyn, 2011; Rumbelow, 2009). It is commonly 
associated with images of sexuality, or of feeding 
difficulties, rather than being seen as a normal, 
unremarkable, and fundamental aspect of parenting 
(Henderson et al, 2000). As a result, when women 
encounter serious but preventable problems with 
breastfeeding (such as embarrassment and isolation 
when breastfeeding in public, painful breasts and 
nipples as a result of not understanding how to 
effectively attach the baby to the breast, and anxiety 
about their milk supply), they may struggle to find 
appropriate care and support. This may lead to their 
families, friends, and health professionals advocating 
that they solve the problem by using formula 
instead (Dykes, 2006). Women’s choice to start or to 
continue to breastfeed is therefore constrained by 
the culture and community in which they live. 
An important economic consequence is that without 
an adequate environment and support services to 
enable breastfeeding, women will experience high 
rates of preventable problems that will be:
•	 an avoidable burden to the health services
•	 the cause of premature discontinuation of 
breastfeeding: 90% of women who discontinue 
breastfeeding report that they do so before they 
want to (Bolling et al, 2007)
•	 substantial family concern and distress. 
1.5 Enabling women to breastfeed
Ways of supporting and enabling women to 
breastfeed in this context have been identified, 
and many are now included in national strategy 
and guidance (for example, Renfrew et al, 2012, 
Dyson et al, 2008; National Institute for Health 
and Clinical Excellence, 2008 updated 2011; 
UNICEF UK BFI, 2012; Department of Health, 
2009). But implementation of these interventions 
remains inconsistent, even in communities where 
breastfeeding rates are lowest and the need for such 
action is arguably highest (Dyson et al, 2012). 
The complex mix of socio-economic, clinical and 
health service challenges requires a strategic, 
coordinated, multifaceted approach if rates of 
breastfeeding duration, especially the duration of 
exclusive breastfeeding, are to increase (Dyson et al, 
2006). Developments in UK policy to address these 
challenges have already led to greater numbers of 
women starting to breastfeed (Information Centre 
for Health and Social 
Care, 2011). It is 
essential that more 
women are supported 
to breastfeed and 
enabled to continue in 
order to avoid feeding 
problems, distress, 
disappointment, 
and possibly the 
premature introduction 
of breastmilk substitutes – all of which are likely 
to contribute to the perpetuation of the idea 
that it is difficult to breastfeed. This will require 
resources for staff training, service provision, and 
for dissemination of information and evidence to the 
wider public. An economic perspective is essential 
to provide policymakers and service commissioners 
with information to use in decision-making about 
spending priorities, especially in times of severe 
resource constraints.
The economics of infant feeding
To understand the economic consequences of 
infant feeding, two forms of economic evidence are 
needed: first, evidence of the scale of the cost of low 
breastfeeding rates in relation to the consequences 
for health and related outcomes; second, 
evidence on the cost-effectiveness of the range 
of interventions needed to promote and protect 
breastfeeding, and to support women to breastfeed. 
These then need to be considered in the light of local 
and national circumstances.
The main focus of this study is the health service 
costs incurred as a result of treating diseases 
resulting from not breastfeeding, including costs in 
both primary and secondary care. There are other 
economic considerations, such as the economic 
consequences outside of the health sector: for 
instance, education and the wider economy. The 
costs of enabling women to breastfeed include 
both direct costs to the health service such as staff 
training and offering support, and costs to society. 
An economic perspective 
is essential to provide 
policymakers and service 
commissioners with 
information to use in 
decision-making about 
spending priorities, 
especially in times of severe 
resource constraints.
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From an economic perspective, the costs of treating 
disease should therefore be balanced against the 
health service costs and other actions needed to 
promote and support breastfeeding as well the 
value of health benefits. This is considered further in 
Section 5 of this report.
The precise balance of costs saved and incurred 
through changing infant feeding patterns will be 
different across countries and communities. For 
example, in the USA there is very limited maternity 
leave, so women who take time off work to be with 
their babies will incur significant loss of earnings 
(Rippeyoung and Noonan, 2012). The effect on 
women’s earnings in the UK, where maternity leave 
has increased significantly in recent years, will be 
much less. In Norway and Sweden, where the great 
majority of women breastfeed, cultural norms are 
such that women can breastfeed in public without 
fear of harassment, and children learn about and 
understand breastfeeding, so actions to address 
these issues are not needed as they are in the UK 
(Lande et al, 2003; Akerstrom et al, 2007). 
It is difficult therefore to generalise about the 
economic consequences of infant feeding patterns 
across countries.
The implications will also vary across communities 
within countries. For example, breastfeeding 
rates vary widely across the UK, related to socio-
economic status, ethnicity, and age (Bolling et 
al, 2007, Child and Maternal Health Observatory, 
2012). Initiation rates in primary care trusts (PCTs) 
in England vary from 42.5% to 92.5% and rates of 
any breastfeeding at 6–8 weeks range from 19.4% 
to 83.2% (ChiMat Data Atlas, 30 August 2012 http://
bit.ly/Ry4k39. Some more affluent communities, or 
communities with high representation of minority 
ethnic groups, are likely to require fewer actions 
to increase breastfeeding rates than low-income 
communities with lower rates of initiation and 
duration. Interpreting the findings of this study for 
different UK communities will therefore require 
an analysis of the actions needed to address the 
specific circumstances of the local population. 
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2 AIM AND OBJECTIVES OF THE STUDY
The overarching aim of this study was to provide 
decision-makers with evidence from a UK health 
service perspective on the economic consequences 
of diseases and conditions preventable by 
breastfeeding. Specifically, this study examined the 
potential contribution of increasing breastfeeding 
rates to preventing disease and saving resources in 
the context of the UK.
To achieve the aim of the study, we have examined 
whether cost savings to the health service would 
accrue as a result of increased rates of exclusive 
and partial breastfeeding. Short, medium and 
longer term disease outcomes for both mother and 
infant have been examined, and outcomes for both 
healthy infants and those in neonatal units have 
been included. The study used evidence derived 
from epidemiological studies, economic modelling, 
and a narrative economic analysis where modelling 
was not appropriate. We have used a systematic 
approach at all stages to ensure that we used 
the best available evidence, and we have been 
transparent about our decisions at each stage. 
Increasing rates of initiation, duration and exclusivity 
of breastfeeding will only be achieved by investing 
in promotion and protection of breastfeeding, and 
support for women (NICE, 2008). In Section 5.3, we 
have provided an illustrative example of the cost of 
implementing a multifaceted programme of evidence-
based change in one region, to help to contextualise the 
findings for decision-makers at local and national levels. 
Examining the economic consequences to the 
health service is an essential first step in measuring 
the economic impact of infant feeding patterns in 
the UK. The full economic impact is likely to reach 
well beyond the health service to include education, 
employment and other related sectors. This has 
been considered briefly, as part of three narrative 
analyses, to illustrate the potential scale of the 
economic impact of low breastfeeding rates.
The wide range of different economic consequences 
of infant feeding patterns to society, government and 
community, and to the mother, baby and family, is 
considered in Section 5.5 of this report. 
The study was conducted by a multidisciplinary 
team with expertise in systematic reviews, statistics 
and epidemiology, health economics, health policy, 
and infant feeding. Team members had clinical 
backgrounds in neonatology and midwifery, and one 
team member was a service user representative. 
A multidisciplinary Advisory Group informed the 
development of the study and agreed the final report. 
A full listing of the membership of the research team 
and Advisory Group is shown in Appendix 1. The 
final report was sent to an international panel of peer 
reviewers and their changes and comments were 
subsequently considered and incorporated.
2.1 Issues with research in this field
Determining the costs of health outcomes related 
to infant feeding relies on the ability to estimate the 
scale of differences in occurrence of those outcomes 
depending on feeding method. Randomised 
controlled trials are very rare in this field. It is seldom 
either ethical or feasible to randomise women to 
breastfeed or not; although some trials of relevant 
interventions exist (Kramer et al, 2001; Quigley et al, 
2007b). Analysis in this field therefore relies mainly 
on observational data. An important aspect of this 
analysis is the ability to control for confounding 
variables, such as socio-economic background, or 
other systematic differences between women who 
breastfeed and those who do not. 
A second issue is that there is no clear dividing line 
between ‘breastfeeding’ and ‘not breastfeeding’. Women 
in the UK often use mixed feeding methods, either out of 
choice or as a result of constraints such as experiencing 
feeding problems or having to be away from their baby. 
The great majority of babies who start to breastfeed 
in the UK are fed on a mix of breastfeeding and other 
food and fluids, including infant formula, follow-on 
formula, and solids (Bolling et al, 2007). 
As a result of these issues, two errors are possible. 
First, estimates of difference between health 
outcomes for women and babies who breastfeed 
and who do not breastfeed might be overestimated; 
for example, because of insufficient control for 
confounding factors (Horta 2007; Kramer 2009). 
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Were this to happen, the costs of possible diseases 
and conditions resulting from low breastfeeding 
rates would be calculated as higher than they should 
be. Second, the estimates of difference could be 
underestimated, and the costs would be calculated 
as lower than they should be; for example, because 
of the measurement error associated with treating 
breastfeeding as a dichotomous variable (Kramer 
2009). Both of these would constitute serious 
methodological errors. 
In this study we have adopted a methodological 
approach that is both systematic and transparent, 
taking care not to overestimate or underestimate the 
burden of disease or the costs resulting from artificial 
feeding. To avoid the risk of overestimation of costs, 
we consistently erred on the side of conservative 
assumptions when making methodological decisions.
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3 METHODS
3.1 Introduction
A range of methods was used as follows: 
Systematic identification of evidence from the UK 
and similar high-income industrialised countries 
about economic consequences of diseases 
preventable by breastfeeding:
•	 A systematic search and identification of 
existing systematic reviews and UK studies of 
disease outcomes related to breastfeeding (at 
all, or exclusively)
•	 Systematic identification of strongest  
sources of evidence most relevant to the UK 
and similar countries
•	 A review of studies related to economic  
impact (cost of illness) of not breastfeeding  
(at all, or exclusively)
 
Calculating measures of effect and other  
summary statistics:
•	 Statistical analysis of the findings of relevant 
studies and reviews to produce summary 
statistics for the cost of illness models
 
Developing cost of illness models and  
narrative analyses:
•	 Development of cost of illness models, 
including identification of data to inform the 
prevalence and costs of disease
•	 Narrative analysis of the economic issues 
related to outcomes with extensive impact on 
health and on other sectors that could not be 
included in an economic model 
Setting the findings in context:
•	 Illustrative example of the resources needed 
to implement a multifaceted, evidence-based 
change programme in one locality
•	 Examination of UK contextual evidence and 
policy, drawing on recent policy documents and 
systematic reviews  
 
This section summarises the methods used for each 
stage of the study. Full descriptions of methods used 
are included in Appendices 2–16.
3.2 Searches to identify relevant evidence 
Identifying the evidence to inform the cost of  
illness models was an essential foundation to  
this study. We needed to identify systematic  
reviews and studies that could provide good quality 
evidence related to a very wide range of disease 
outcomes relevant to a UK setting. Challenges in  
this process included: 
•	 the extensive volume of literature in the field  
of infant feeding
•	 some studies and reviews examined only  
one outcome, while others examined a range  
of outcomes
•	 some reviews combined studies from 
developed and developing country settings
•	 some studies and reviews had rigorous 
methods for measuring exposure (initiation, 
duration and exclusivity of feeding methods), 
while many did not
•	 randomised controlled trials are seldom possible 
in this field, and existing studies and reviews do 
not always use robust analytical methods
•	 variation in the extent and nature of controls for 
confounding variables, and some studies do not 
control for these at all.
 
Only after assessing the strength of evidence was 
it possible to decide if any specific disease outcome 
could be included or excluded, and for some 
outcomes the evidence from different studies and 
reviews was conflicting. 
The searches therefore had to be broad and 
inclusive, and the process of identifying included 
studies and reviews was conducted in a stepped 
process. A hierarchy of evidence was developed to 
assist in the final identification of relevant evidence. 
We conducted three separate reviews to identify 
relevant information, each with its own purpose, 
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and inclusion and exclusion criteria. See Appendix 
3 for full details of search strategies and databases 
searched, and Appendix 4 for screening criteria for 
titles and abstracts for each of the three reviews: A, 
B and C.
Review A: a systematic search and identification 
of existing systematic reviews of infant feeding 
and health and cognitive outcomes in developed/
transitional countries.
The following inclusion criteria were used at the 
stage of screening the search results:
•	 Some or all participants breastfeeding/feeding 
with breastmilk 
•	 Measured health and/or cognitive outcomes in 
relation to infant feeding 
Exclusion criteria were:
•	 Reviews including only studies conducted in 
developing countries
•	 Not a systematic review
Review B: a systematic search and identification of 
UK studies examining health outcomes related to 
infant feeding. 
The following inclusion criteria were used at the 
stage of screening the search results:
•	 Controlled studies conducted in the UK
•	 Some or all participants breastfeeding/feeding 
with breastmilk
•	 Measured health and/or cognitive outcomes in 
relation to infant feeding
Review C: a review of economic impact (cost of 
illness) related to infant feeding from developed/
transitional countries.
The following inclusion criteria were used at the 
stage of screening the search results:
•	 Cost analyses or cost of illness studies
•	 Conducted in the UK or comparable 
industrialised countries 
•	 Measured costs to health services of treating 
conditions that could have been prevented by 
breastfeeding
•	 Measured costs to other public services of 
meeting needs that could have been prevented 
by breastfeeding
3.2.1 Search results
Review A
The search results were delivered in two parts: 
English and languages other than English.
English search results 
One researcher (FM) screened the titles and 
abstracts (n=9,671) using a pre-screening form based 
on the inclusion criteria for Review A (Appendix 4). 
A second researcher (AM) screened a 10% sample 
(n=967) as a quality check. Full papers were ordered 
for all citations where exclusion was not possible 
on the basis of citation and abstract (total of 297). 
214 papers were received as pdf files from journals 
to which the university library subscribes. Of the 
remaining 83, papers were ordered only when they 
related to what became priority outcomes (a total of 
four of these papers were ordered). 
Non-English search results 
1,419 non-English citations were identified, 638 with 
an English abstract. One reviewer (FM) assessed 
these on title and abstract, and the remainder on title 
only, using the same pre-screening form. A second 
reviewer (AM) screened a 10% sample (n=142) as 
a quality check. Two further papers were ordered 
(seven others identified had already been ordered in 
translation during the English search process). 
Review B
One reviewer (FM) screened the titles and abstracts 
(n=3,527) using a form based on the inclusion criteria 
for Review B (Appendix 4). A second reviewer (AM) 
screened a 10% sample (n=353) as a quality check. 
Full papers were ordered for all citations where 
exclusion was not possible on the basis of citation 
and abstract (total of 253).
Review C
The search for economic evaluations of infant 
feeding delivered 2,415 citations in an Endnote 
database. One experienced reviewer who is 
UNICEF UK
Preventing disease and saving resources: 
the potential contribution of increasing breastfeeding rates in the UK  25
not an economist (FM) and one economist (SP) 
independently piloted the screening process on 
the first 242 citations (10% of 2,415), using the 
pre-screen form shown in Appendix 4. There was 
full agreement between the two reviewers on the 
included and excluded papers. The remaining titles 
and abstracts (2,215/2,415) were therefore screened 
by one reviewer (FM). Copies of 37 papers were 
requested as a result of this process. Eleven papers 
were reviewed and data extracted. The results of 
this review, including descriptions and appraisals of 
the included studies, conclusions and data extraction 
forms, are shown in full in Appendix 5.
3.2.2 Identifying relevant systematic reviews and  
UK studies and identifying priority outcomes 
for further appraisal
The goal of this stage was to use these systematic 
reviews and UK studies to identify a shortlist of 
priority outcomes that had sufficient good quality, 
relevant evidence to inform the economic analyses.  
 
We planned to identify short, medium and long-
term disease outcomes for the child including 
babies in neonatal units, maternal outcomes, and 
developmental outcomes for the child. 
Identifying the priority outcomes took place in several 
stages over which papers were gradually excluded, 
as follows. The 552 papers identified in the screening 
process (299 from Review A and 253 from Review 
B) were scanned to identify the outcomes examined, 
and divided into individual databases for each 
outcome identified. Papers where multiple outcomes 
were examined, and where those outcomes were 
identified as priorities, were added to more than 
one database. Where systematic reviews included 
studies from both developed and developing 
countries, they were examined to identify any 
relevant UK studies. The numbers of possible papers 
identified in the screening process and allocated to 
different categories are shown in Table 1.
Table 1: Numbers of possible papers (n=552) identified in  
the screening process and allocated to different categories
Category  to which papers allocated Number of papers 
allocated 
Comment
Excluded 199 Not relevant – for example, not a systematic review  
or UK study, not related to the topic
45 outcomes where evidence did not 
meet our criteria
173 Shown in Appendix 6
Papers to be further examined 
(categorised below)
180 These papers were included on a long list for detailed 
examination and discussion and finally allocated to one 
of the categories below
Total papers from screening 552
•	 Studies with multiple outcomes 18 One or more outcome from these studies appears 
in one or more of:  final shortlist, final long list, 45  
outcomes where evidence did not meet our criteria
•	 Final shortlist of eight outcomes for 
economic analysis
100 These were further scrutinised – details in section 
4.1.1
•	 Final long list of further eight 
outcomes 
62 Did not meet criteria for economic analysis. Details in 
section 4.1.2
Total papers to be further examined 180
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Outcomes where evidence was clearly inadequate 
for our purposes (for example, no systematic review 
or UK study existed) were excluded at this stage 
(n=199 papers). Outcomes where the evidence 
clearly did not meet our criteria were included on a 
list for future research (45 outcomes, 173 papers, 
Appendix 6). Outcomes where systematic reviews 
or UK studies that were assessed at this preliminary 
stage as having the potential to be adequate were 
included on a list of possible outcomes for inclusion 
(n=180). 
Using an iterative process to examine the strength 
and relevance of evidence related to each outcome, 
the long list was then assessed by the research team 
and the Advisory Group using the following criteria:
•	 one or more reviews or studies had been 
identified that either had the potential to predict 
the effect size with confidence, or the evidence 
was not conclusive but the effect size was likely 
to be considerable
•	 it was scientifically plausible that the outcome 
could be related to infant feeding
•	 the outcome was assessed as important in a 
UK setting
•	 it was possible to conduct an economic analysis 
(that is, data existed in a useable form).
This process included the identification of the studies 
with the best quality of data for our purposes. For 
this, we had to develop a process for agreeing 
the best source of data to inform our economic 
analyses. This involved the assessment of the quality 
of evidence, and of the biological plausibility of the 
condition being affected by infant feeding.
3.2.3 Quality assessment and hierarchy of evidence 
Randomised controlled studies in this field are 
very rare. We therefore anticipated that conducting 
analyses of available data would be complicated by: 
methodological problems in the original studies, the 
limited occurrence of exclusive breastfeeding, a wide 
range of different measures used for feeding history 
and for outcomes, and different findings related 
to diverse settings and population group. These 
factors would be likely to contribute to conflicting 
findings between reviews and between UK studies 
and review. We were also aware that the evidence 
available was likely to differ in quantity, quality and 
relevance between outcome. The strategy we 
adopted to guide our analysis was to construct a 
stepped approach to identifying the best quality 
and most appropriate evidence, using a hierarchy of 
evidence appropriate for this study and which could 
be tailored to each outcome. 
For each priority outcome, we planned to identify a 
primary source or sources of evidence; if possible, 
we planned to conduct meta-analyses to combine 
data from different studies. We also planned 
to identify alternative or corroborative evidence 
from other sources that could confirm the size of 
effect identified in the primary source. The primary 
source of evidence might be either a UK study or 
a systematic review, depending on the quality of 
available evidence for each outcome. The process for 
identifying appropriate evidence is outlined in Table 
2. In addition to this hierarchy, a prerequisite for any 
study used was that it reported data by infant feeding 
method, and that it reported adequate measures 
of exposure (initiation, duration, exclusivity) to 
breastfeeding and use of breastmilk substitutes.
As the assessment of the characteristics of 
appropriate studies and reviews varied between 
outcomes, individual discussions involving the 
whole research team took place to agree each 
primary data source. For example, the assessment 
of a ‘large enough’ study required examination of 
the sample size to assess that individual outcome, 
and that would vary according to whether the 
outcome was common (for example, gastrointestinal 
disease) or relatively rare (for example, necrotising 
enterocolitis). Assessment of ‘adequately controlled’ 
required examination of related factors (for example; 
for obesity, was maternal BMI controlled?). The 
outcome of these discussions, and reasons for 
inclusion/exclusion of each study or review, are 
shown in the Results sections for each outcome. 
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Table 2: Hierarchy of evidence used for each outcome to  
identify the reviews and studies to inform the economic models.
Level of evidence Primary source of evidence Corroborative evidence
Level 1 One or more UK studies: the research team 
had to agree that it was contemporary, large 
enough, good quality, adequately controlled 
– these assessments had to be related to 
the outcome of interest and varied from 
outcome to outcome 
Systematic reviews, UK studies not meeting 
Level 1 criteria
Studies from other countries identified from 
systematic reviews
Level 2 Good quality meta-analysis or systematic 
review using studies from developed 
countries
Other systematic reviews
UK studies not meeting Level 1 criteria 
Studies from other countries identified from 
systematic reviews
Level 3 One or more UK studies not meeting  
Level 1 criteria
Systematic reviews
Studies from other countries identified from 
systematic reviews
Level 4 Systematic review not meeting  
Level 2 criteria
Other systematic reviews
Studies from other countries identified from 
systematic reviews
3.2.4 Plausibility
A final important factor in our decision-making on 
the final shortlist of priority outcomes was biological 
plausibility – how likely is it that the outcome will 
be affected by infant feeding? Outcomes included 
on the final shortlist were those where plausible 
biological mechanisms exist, even if these are not 
yet fully understood. Mechanisms related to each 
of our shortlisted outcomes are summarised in 
Appendix 7.
3.2.5 Identification of priority outcomes: the shortlist
These are discussed in detail in Results: Section 4. 
They are reported briefly here as the next stages 
of the Methods required work on these specific 
outcomes. 
Five outcomes were identified for quantitative 
economic modelling: 
•	 In the infant 
– Gastrointestinal disease, lower respiratory 
disease, and acute otitis media 
•	 In infants in neonatal units 
– Necrotising enterocolitis (NEC)
•	 In mothers 
– Breast cancer
Three outcomes were identified for narrative 
economic analysis, all related to the infant/child:
•	 Cognitive outcomes
•	 Sudden Infant Death Syndrome (SIDS)
•	 Early years obesity 
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3.2.6 Data extraction and quality appraisal 
Systematic reviews and UK studies relating to the 
agreed shortlist were identified. Data were extracted 
by one reviewer (FM) and checked by another (MQ), 
and any difficulties discussed with MJR and on many 
occasions with the whole research team. Problems 
encountered included:
•	 the poor quality of exposure measurement 
(initiation, duration, exclusivity) of infant feeding
•	 the lack of consistency in the timing of exposure 
measures (examples included any breastfeeding 
to 6–8 weeks, still breastfeeding at time of 
occurrence of outcome, received any breastmilk)
•	 the limited occurrence of exclusive 
breastfeeding in developed country settings, 
resulting in most comparisons being 
confounded by mixed feeding
•	 very few randomised controlled trials exist due 
to ethical and practical problems of randomising 
feeding methods
•	 the close association of feeding with socio-
cultural or other relevant factors, which may or 
may not have been controlled for in studies  
or reviews
•	 inadequate sample sizes.
3.3 Statistical issues
3.3.1 Calculating effect measures, exposure, 
adjustment for confounders, risk ratios versus  
odds ratios 
We used the findings of the systematic reviews  
and UK studies identified for the shortlisted 
outcomes as follows:
•	 For each of the primary sources of data 
identified for each of the shortlisted outcomes, 
we obtained risk ratios or odds ratios as 
appropriate (Appendix 2, section 1.6)
•	 For each of the shortlisted outcomes, exposure 
to infant feeding methods (that is, initiation, 
duration and exclusivity of breastfeeding) was 
grouped as appropriate (Appendix 2,  
section 1.6.2)
•	 For each of the shortlisted outcomes, it was 
appropriate to use risk ratios or odds ratios 
which were adjusted for confounders, since 
none of the included UK studies or meta-
analyses were randomised controlled trials, and 
infant feeding is known to vary according to 
many socio-cultural factors. For each study, we 
assessed whether adjustment for confounders 
was deemed as adequate. For almost all 
outcomes, it was deemed as adequate and the 
factors which have been adjusted for are clearly 
described in the Results chapter and described 
in detail in data extraction tables in Appendix 11 
•	 The original adjusted odds ratios were used 
in the economic models; details of the 
methodological considerations are shown in 
Appendix 2, section 1.6. 
3.3.2 Population attributable fractions
We originally planned to use the population 
attributable fraction (PAF) to estimate the proportion 
of cases that were attributable to not breastfeeding. 
However, this proved to be difficult because the 
standard formulae for PAF (Bruzzi et al, 1985) are for 
exposures that result in an increased risk of disease 
(for example, smoking) rather than a protective 
effect. Methodological details are in Appendix 8. 
3.4 Economic modelling
The aim of the economic modelling was to estimate 
the savings in the NHS treatment costs that could 
be achieved if breastfeeding rates increased and 
incremental quality adjusted life years (QALYs) 
that might be accrued in the case of breast cancer. 
QALYs were not estimated in relation to other 
outcomes modelled as they were acute diseases 
with a short time horizon. Objectives were to: 
a) estimate current costs to the NHS of treating 
diseases shown to be associated with 
breastfeeding given current breastfeeding rates 
b) predict the impact of increased breastfeeding on 
selected diseases given varying rates/definitions 
of breastfeeding 
c) estimate potential cost-savings per year, if 
any, that could be achieved by moving from 
the current breastfeeding rates to a particular 
breastfeeding rate/definition; and
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d) estimate QALYs gained and incremental benefit 
(combined value of QALYs with treatment 
costs) for reduction in breast cancer cases in a 
cohort of parous women
For each of the disease outcomes to be modelled, 
one or more odds ratios were selected to model the 
benefit of breastfeeding. Variation in key elements 
of the studies that generated odds ratios, such as 
variation in the definition of breastfeeding (both 
in terms of exclusivity and duration) and the time 
period in which such benefits accrued, meant that 
each outcome had to be modelled separately. For 
acute conditions (gastroenteritis, respiratory illness 
and acute otitis media), the first year of life was 
considered as the time horizon for costing whereas 
for maternal breast cancer it was lifetime of a cohort 
of parous women. For necrotising enterocolitis 
(NEC), it was the length of stay in neonatal units. 
The perspective of the economic analysis was that 
of the NHS in the UK. Costs associated with not 
breastfeeding that fall on individuals or households 
and/or any other sectors were excluded, as were 
any costs of interventions to promote breastfeeding. 
Data on treatment costs and potential cost-savings 
are presented in 2009–10 prices. Where the costing 
time horizon is longer than a year (for example, 
maternal breast cancer), a rate of 3.5% was used 
to discount the future stream of treatment costs in 
baseline estimates (National Institute for Health and 
Clinical Excellence, 2006a).
A separate evidence review was carried out to 
establish the following information to inform 
modelling (model parameters): current breastfeeding 
rates; incidence of outcomes; incidence of primary 
and secondary care episodes specific to the selected 
conditions; unit costs of treatment of the condition 
or unit-costs of care episodes. This review relied 
on the most recent publications (for example, 
National Institute for Health and Clinical Excellence 
guidance, National Institute of Health Research 
Health Technology Assessment reports, and peer-
reviewed journal articles) and hand-searching of the 
bibliographies of those papers. All model parameters 
are specific to the UK. A commentary on evidence 
appraisal and synthesis is included for each model 
and provided as Appendix 9. 
3.4.1 The 7-step framework 
A framework was developed to inform the modelling 
of all the outcomes identified, building on common 
methods adopted by previous studies (Weimer, 
2001; Drane, 1997; Bartick and Reinhold, 2010). 
The common steps that were followed across all 
outcomes are summarised here and in Figure 1, and 
full details are included in Appendix 2, section 2.1.
Developing breastfeeding policy scenarios
The aim of the modelling exercise was to estimate 
the extent to which NHS treatment costs would 
be reduced if breastfeeding rates were increased. 
Therefore, various breastfeeding policy scenarios 
relative to a ‘base case’ were needed from which to 
simulate any cost-savings associated with increased 
breastfeeding. The variations in the definition of 
breastfeeding (both in terms of exclusivity and 
duration), the source of data on breastfeeding rates, 
and the time period in which benefits accrued due to 
breastfeeding meant that a ‘universal’ policy scenario 
was not applicable across the five outcomes 
considered. Therefore, outcome-specific policy 
scenarios were developed. Both the description and 
the rationale for these are described in the outcome-
specific methods sections (below, section 3.4.2). 
Determine the reference population 
The reference population selected was either 
children born in the year 2009 (for child outcomes), 
sourced from data provided by the Office for National 
Statistics (ONS), or a cohort of primiparous women 
– first time mothers – (for maternal outcome), 
sourced from Euro Peristat (EURO-PERISTAT 
project in collaboration with SCPE EUROCAT & 
EURONEOSTAT, 2008).
Divide the reference population between 
breastfeeding groups
The reference population was divided into two 
groups – breastfed children or breastfeeding women 
and non-breastfed children or not-breastfeeding 
women – using breastfeeding rates derived from the 
Infant Feeding Survey (Information Centre for Health 
and Social Care, 2011), (Bolling et al, 2007), or from 
Liu et al (Liu et al, 2009) for breast cancer. This was 
used to estimate the expected number of children/
women who would be breastfed/breastfeeding 
under each policy scenario. 
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Estimate expected number of disease/care episodes 
in each feeding group
The expected number of children or women 
experiencing the outcome of interest was estimated 
in each feeding group for each policy scenario. 
The differential incidence was obtained using the 
formula provided by Bartick and Reinhold (Bartick 
and Reinhold, 2010): x= s/(br+1-b), where x= disease 
incidence in non-breastfeeding group,  
s = overall incidence of the disease in question,  
b = current breastfeeding rate; r=odds ratio in favour 
of breastfeeding, and xr= incidence of the condition 
in breastfeeding group. This formula is applicable 
when the odds ratio approximates the risk ratio.
Estimate total costs of treatment per year in each 
breastfeeding group under each policy scenario
The estimated number of children or women with the 
outcome of interest fed into the calculation of costs by 
estimating incidence of care episodes and multiplying 
by unit cost of a care episode (hospitalisation or GP 
visit). The costs in each feeding group were summed 
for total costs of the disease under each policy 
scenario. For maternal breast cancer, a cohort of 
100,000 women were followed up over their lifetime, 
using a simple 3-state Markov process (cancer, no-
cancer, death), to estimate the treatment costs. 
Estimate total potential cost-savings per annum 
under different policy scenarios
Total treatment costs per year under each policy 
scenario were compared with the base case 
to ascertain the extent to which increasing 
breastfeeding rates would reduce health service 
costs. In the case of breast cancer, an additional 
metric – the incremental benefit that combines 
the value of QALYs with treatment costs – was 
estimated. The findings present the potential savings 
to the NHS that might result from increased rates 
of breastfeeding. No attempt has been made to 
estimate the net benefit to the NHS, which would 
require subtracting the costs of the interventions 
used to promote and support breastfeeding. These 
are discussed in Section 5.2 to help to contextualise 
the potential savings. 
Reflecting some degree of uncertainty in  
predicted cost-savings
Parameters used in the modelling exercise (for 
example, odds ratio and treatment costs) were 
derived from studies and reviews with varying 
characteristics (for example, design, sample size, 
definition of breastfeeding). Inevitably, there is some 
degree of uncertainty about the point estimates 
reported in individual studies and, in some instances, 
the degree to which these are applicable to a UK 
NHS setting. Deterministic sensitivity analyses thus 
assessed the impact on the predicted cost-savings 
of the uncertainties around odds ratio and unit costs 
of treating the health-outcomes. These parameters 
were selected to capture the changes in both 
outcomes (expected number of cases) and costs to 
treat those cases. Methods used are shown in detail 
in Appendix 2, section 2.1.
This 7-step framework is similar to the methods 
adopted by similar studies conducted in non-UK 
settings (Weimer, 2001; Drane, 1997; Bartick and 
Reinhold, 2010. However, it builds on the previous 
methods by:
a) including more realistic policy scenarios for 
four of the five priority outcomes (excluding 
necrotising enterocolitis), based on our  
critical analysis of existing UK-specific 
breastfeeding data, rather than just relying  
on a hypothetical target 
b) limiting, to the extent possible, the use of  
model parameters from the same setting; and 
c) reflecting some degree of uncertainty in final 
estimates of cost-savings through a range of 
deterministic sensitivity analyses. 
In addition, the selection of risk ratios on which the 
current models work is the outcome of a series of 
structured reviews undertaken specifically for this 
project. Together, they make the current study more 
robust and relevant to the UK context. 
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Figure 1
Schematic diagram of 7-step process of 
economic modelling
Reflecting uncertainty in
predicting cost savings
Step  7
Develop a breastfeeding
policy scenario
Step  1
Determine reference population
for each outcome
Repeat this process for each breastfeeding scenario
Step  2
Determine total cost
of care expected
Step  5
Estimate potential 
cost-savings
Step  6
Determine population
not breastfeeding
Step  3
Determine population
breastfeeding
Step  3
Determine number of disease
or care episodes
Step  4
Determine number of disease
or care episodes
Step  4
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3.4.2 Outcome-specific methods 
Policy scenarios
As Figure 1 shows, methods were developed 
specifically for each outcome modelled. Full details 
are given in Appendix 2, section 2.2, and see 
Appendix 10 for policy scenarios modelled and key 
parameters used for five disease outcomes.
A key part of the modelling was the development 
of a range of realistic options for increased rates 
of breastfeeding (section 3.4.2.1). These policy 
scenarios varied from outcome to outcome. In 
developing these UK-wide scenarios, we recognised 
that breastfeeding rates are very diverse across 
localities. Initiation rates in PCTs in England vary 
from 42.5% to 92.5%, for example, and rates of any 
breastfeeding at 6-8 weeks range from 19.4% to 
83.2% (ChiMat Data Atlas, 3 August 2012 http://bit.
ly/OETfjL. 
 
The work needed to increase breastfeeding rates will 
therefore vary from locality to locality. 
To ensure that the national scenarios were realistic 
in the UK context, we used existing UK rates as the 
basis for our calculations. We assumed that with 
appropriate care and support, and noting that 90% 
of women in the UK who stop breastfeeding before 
six weeks do so before they wish to (Bolling et al, 
2007), women throughout the UK could continue to 
breastfeed for considerably longer than at present. 
So, for example, scenario A1, shown below, was to 
increase the rate of breastfeeding at four months 
to the current rate at six weeks (21%). The rates 
we have chosen are lower than those seen in other 
European countries (Huus et al, 2008).
Table 3: Policy scenarios modelled for predicting the impact of  
increased breastfeeding rates on gastrointestinal infection, lower  
respiratory tract infection, and acute otitis media in infants against  
varying rates/definitions of breastfeeding. 
Definition of breastfeeding 
and rate used (2005) in 
base case
Alternative policy scenarios modelled
Scenario A0 (current rates): 
Exclusive breastfeeding (EBF) 
rate at 4 months (7%)
A1: increase rate of exclusive 
breastfeeding at 4 months to 
rate at 6 weeks (21%)
A2: increase rate of exclusive 
breastfeeding at 4 months to 
rate at 1 week (45%)
A3: increase rate of exclusive 
breastfeeding at 4 months to 
rate at birth (65%)
Scenario B0:  
Exclusive breastfeeding (EBF) 
rate at 6 months (0.5%)
B1: increase rate of exclusive 
breastfeeding at 6 month to 
rate at 4 months (7%)
Scenario C0:  
‘any breastfeeding’ rate at  
6 months (25%)
C1: increase rate of ‘any 
breastfeeding’ at 6 months to 
rate at 6 weeks (48%)
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Table 4: Policy scenarios modelled for predicting the impact  
on necrotising enterocolitis (NEC) of increasing rate of  
breastmilk feeding for varying rates of ‘any breastmilk  
feeding’ at discharge within neonatal units
Definition of breastmilk 
feeding and rate used 
(2006) in base case
Alternative policy scenarios modelled
Scenario D0: (current 
rates): Any breastmilk 
feeding rate at discharge 
from neonatal units (35%) 
Scenario D1: increase rate 
of any breastmilk feeding at 
discharge from neonatal  
units to 50%
Scenario D2: increase rate 
of any breastmilk feeding at 
discharge from neonatal  
units to 75%
Scenario D3: increase rate 
of any breastmilk feeding at 
discharge from neonatal  
units to 100%
Table 5: Policy scenarios modelled against current practice  
for predicting the impact of increased breastfeeding on  
maternal breast cancer.
Definition of ‘lifetime’ 
breastfeeding and rate 
used (1996-2001) in  
base case
Alternative policy scenarios modelled
Scenario E0  
(current rates):
32% parous women never 
breastfeeding 
36% breastfeeding for  
≤6 months 
16% breastfeeding for  
7-18 months
16% breastfeeding for  
18+ months
Scenario E1: 
Increase rate of 
breastfeeding  for ≤6 
months to 52%
16% never; 
52% ≤6 months;
16% 7-18 months 
16% 18+ months
Scenario E2: 
Increase rate of 
breastfeeding for ≤ 18 
months to 32%  
16% never 
36% ≤6 months 
32% 7-18 months 
16% 18+ months
Scenario E3: 
Increase rate of 
breastfeeding for 18+ 
months to 32%
16% never 
36% ≤6 months 
16% 7-18 months 
32% 18+ months
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Odds ratios
Odds ratios for the difference in disease prevalence 
related to different infant feeding patterns used for 
each outcome are shown in Section 4.3 for each 
model, and the basis of their calculation is shown in 
detail in Appendix 2, Section 2. 
3.4.3 Methods of narrative economic analyses 
We developed narrative commentaries to consider 
the financial impacts of the three conditions where 
quantitative modelling was not possible: cognitive 
outcomes, Sudden Infant Death Syndrome 
(SIDS), and early years obesity. These analyses 
are necessarily less detailed than the quantitative 
models, as data on both prevalence and costs 
were more limited. For each outcome examined, 
we investigated the conditions and the potential 
benefits that might accrue as a result of changes 
in breastfeeding rates. Given the nature of the 
conditions, which are long-lasting and with a wide-
reaching impact, for these outcomes we examined 
some of the savings that could result inside and 
the NHS and in wider society. We used 2009 UK 
data on prevalence and rates where possible. In 
some cases, only data from England and Wales was 
available. In these circumstances, we extrapolated 
from these data to provide UK costings. We drew on 
a range of sources for costing the impact of these 
conditions, including US sources where UK studies 
were not available. The specific sources used for 
each outcome are shown in detail for each narrative 
in Section 4.5. Costs have not been discounted.
3.4.4 Setting the findings in context
To contextualise the findings, we examined UK 
evidence and policy, drawing on recent UK policy 
documents and systematic reviews. In addition, 
we have provided an illustrative example of the 
resources needed to implement a multifaceted, 
evidence-based change programme in one locality. 
This stage of the project is reported in Section 5 and 
Appendices 14–17.
4 RESULTS
4.1 Results of review process to identify priority 
outcomes and examine existing data
All the outcomes examined in studies identified 
in our searches were assessed for adequacy of 
evidence to inform the development of economic 
models. The best available evidence related to a 
“shortlist” of five quantitative and three narrative 
outcomes. A long list of a further eight outcomes 
was also compiled. This consisted of conditions 
in which there was evidence of a relationship to 
not being breastfed, but which was insufficient for 
economic modelling or narrative review. A further 45 
outcomes where evidence was much weaker are 
listed in Appendix 6.
4.1.1 The shortlist of priority outcomes
Table 6 shows the final decisions on eight priority 
outcomes following assessment against the 
selection criteria, together with the 25 systematic 
reviews and UK studies that we identified and 
used in five economic models and three narrative 
analyses. Data extraction tables for these systematic 
reviews and studies forming the evidence base for 
the shortlisted outcomes are shown in Appendix 11.
Final data used to inform the economic models (n=5) 
were developed from the studies identified and are 
shown in Section 4.3. 
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Table 6: Shortlist of eight outcomes for economic analysis,  
where evidence adequate for economic modelling (5) or  
narrative review (3)
Whose outcome What outcome Economic model or 
narrative review
References identified  
(Bold = primary source of data)
Baby/child Gastrointestinal infection Full economic  
model developed
Quigley et al 2006, 2007a
Howie et al, 1990 
Fisk et al, 2011 
Baker et al, 1998
Kramer and Kakuma, 2002 
Baby/child Respiratory tract infection Full economic  
model developed
Quigley et al 2007a
Fisk et al, 2011
Howie et al, 1990
Ip et al, 2007
Bachrach et al, 2003
McNeil et al, 2010
Kramer and Kakuma, 2002 
Baby/child Otitis media Full economic  
model developed
Fisk et al, 2011
Ip et al, 2007, 2009
Babies in neonatal units Necrotising enterocolitis Full economic  
model developed
Henderson et al, 2009
Ip et al, 2007
McGuire and Anthony, 2003
Quigley et al, 2007b
Lucas et al, 1990
Mother Breast cancer Full economic  
model developed
Collaborative Group on 
Hormonal Factors in Breast 
Cancer et al, 2002
Bernier et al, 2000
Lipworth et al, 2000
Ma et al, 2006
Yang and Jacobsen, 2008
Baby/child Obesity Narrative review of  
economic issues 
Horta et al, 2007
Armstrong and Reilly, 2002 
Li et al, 2003 
Reilly et al, 2005 
Wilson et al, 1998
Baby SIDS Narrative review of  
economic issues
Hauck et al, 2011
Child and babies in SCBU Cognitive outcomes Narrative review of  
economic issues
Quigley et al, 2012
Iacovou et al, 2010
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4.1.2 Other outcomes identified
The ‘long list’ of outcomes with important evidence 
to consider
Outcomes included on the final long list were those 
where it was deemed plausible that the outcome is 
related to infant feeding, and where we identified 
evidence to demonstrate the relationship, but where 
the strength of the evidence, or the way in which 
outcomes or infant feeding had been measured, was 
inadequate to inform an economic analysis. There 
were several reasons for this, including 
a) the measurement of infant feeding in the 
available studies did not differentiate adequately 
between exclusive, partial and no breastfeeding, 
b) potentially confounding variables were not 
adequately controlled, and 
c) evidence was not in a form that allowed for 
economic modelling. 
For example, although an increase in the prevalence 
of cardiovascular disease seems likely to be an 
expensive consequence of not breastfeeding it is 
difficult to extrapolate from markers of cardiovascular 
disease in childhood to the actual costs of 
cardiovascular disease in adulthood. This outcome 
could therefore not be included on the final shortlist 
for economic analysis. 
Asthma is another example: asthma is a disease 
where genetics interacts with environmental factors 
and dietary intake, but the majority of studies in the 
field have not addressed this interaction, and many 
have not adequately considered the importance 
of exclusive (as opposed to any) breastfeeding 
and avoidance of any early exposure to potential 
allergenic triggers. Current evidence is conflicting 
and so this outcome was also not included on 
the shortlist. We have included this long list to 
demonstrate the potential extent of the economic 
consequences of not breastfeeding in the UK, which 
is likely to be much greater than the quantitative 
models we have been able to develop, and to act as 
a research agenda for future studies of the costs of 
disease and developmental outcomes. 
Table 7 shows the long list of eight outcomes where 
there was important evidence to consider, but 
where it did not meet our strict criteria for economic 
analysis. These are outcomes where further research 
would help to clarify the effect size associated with 
mode of infant feeding. 
Outcomes for which good quality evidence  
was not identified
Absence of a condition from either the short or long 
list of priority outcomes does not necessarily mean 
that there is no association between that condition 
and infant feeding; it simply indicates current lack of 
good quality evidence. The 45 outcomes identified 
in 173 reviews and studies (Appendix 6) therefore 
represent an important research agenda.
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Table 7: Final long list of eight outcomes: maternal (2) and child (6)  
outcomes where there was evidence of the relationship with infant  
feeding, but where the evidence was not in a form that could be  
used for this study. Reasons for this decision are shown.
Whose 
outcome
What 
outcome
Reason for exclusion 
from short list
Relevant references: systematic 
reviews (SRs) and UK studies
Comment
Mother Ovarian cancer Inadequate evidence for 
modelling (ORs were 
estimated in half the six 
included studies)
Ip et al, 2007/2009 (SR) Important, can be 
costed
Mother Type 2 
diabetes
Evidence from only one 
study (of US nurses, 
Stuebe 2005)
Ip et al, 2007/2009 (SR) Important, can be 
costed, expensive 
chronic disease
Child Asthma Exposure and outcome 
measures inadequate. 
Genetic, environmental 
and dietary factors 
interact. 
Gdalevich et al, 2001 (SR); and 
Davidson et al, 2010, Hide et al, 
1996, Kaplan and Mascie-Taylor, 
1985, Karmaus et al, 2008, Scott et 
al, 2010, Taylor et al, 1983, Turner et 
al, 2008 (UK studies)
Important, costable, 
expensive chronic 
disease
Child Diabetes Inadequate evidence for 
modelling.
Norris and Scott,1996, Owen et al, 
2006 (SRs); and Bodington et al,1994, 
Eurodiab Substudy 2 Study Group 
2002, Jones et al, 1998, McKinney 
et al, 1999, Patterson et al, 1994, 
Robertson and Harrild, 2010, Viner et 
al, 2008, Wadsworth et al, 1997 (UK 
studies)
Important, can be 
costed, expensive 
chronic disease
Child Leukaemia Inadequate evidence for 
modelling.  
Guise et al, 2005, Kwan et al, 
2004 (SRs) and Lancashire et al, 
2003,Murray et al, 2002 (UK studies)
Important, can be 
costed
Child Coeliac 
disease
Inadequate evidence for 
modelling. 
Akobeng et al, 2006 (SR); and 
Challacombe et al, 1997,Kelly et al, 
1989 (older UK studies)
Important, can be 
costed, chronic 
disease
Child Cardiovascular 
disease
Evidence based mainly on 
bio-markers rather than 
disease - inadequate for 
modelling
Das, 2004, Martin, et al 2005a, Owen 
et al, 2003, Owen 2008 (SRs); and 
Owen et al, 2002, Fall et al, 1992, 
Holmes et al, 2010, Khan et al, 2009, 
Lawlor et al, 2008, Martin et al 2004a, 
Martin, et al 2004b, Martin et al 
2005b, Martin, et al 2005c, Pearce et 
al, 2009 and UK studies of premature 
infants, Singhal et al, 2001, Lucas and 
Morley, 1994 (UK studies)
Important, can be 
costed, expensive 
chronic disease
Babies in 
neonatal units
Sepsis Exposure measures 
inadequate
De Silva et al, 2004,Quigley et al, 
2007b (SRs); and Furman et al, 2003 
(US study)
Important, can be 
costed
 
UNICEF UK
Preventing disease and saving resources:  
the potential contribution of increasing breastfeeding rates in the UK38
4.2 Results of economic review
Of the 11 papers reviewed, seven were reported 
from the USA, two from Europe (Italy and the 
Netherlands) and two from Australia. The majority 
(7/11) were published in peer-reviewed journals 
as full papers; two were summary reports in 
peer-reviewed journals and two were reports to 
government departments. All papers were published 
between 1997 and 2010. Of nine papers that were 
published in peer-reviewed journals, four were 
published in paediatric journals.
They varied significantly in terms of methods, 
breastfeeding rates, types of health resource 
used and disease conditions, making it difficult to 
compare the results in a meaningful way. Despite 
this variability, there is a consistent indication that 
increasing the prevalence of breastfeeding would 
lead to substantial reductions in health service costs 
in high income countries. 
Full results of this review are reported in Appendix 5.
There is a consistent 
indication that increasing 
the prevalence of 
breastfeeding would lead 
to substantial reductions 
in health service costs in 
high-income countries.
Katie and Micah
Katie gave birth to Micah nearly 4 weeks early.  
She knew she wanted to breastfeed, but because 
he was premature his sucking reflex wasn’t strong 
and latching on was difficult. Katie recalls that 
staff encouraged her to keep 
trying to breastfeed, but were 
unable to give her any practical 
help. Micah was being given 
formula milk while Katie tried 
to breastfeed. Once she got 
home the community midwife 
and health visitor asked her 
to show them what she was 
doing, and they were able to 
give her some helpful advice 
and establish breastfeeding. They also pointed Katie 
to a local breastfeeding support group in the area, 
where mothers could go to share experiences and 
get advice, which she found very useful.
I had support 
at home from 
the midwife 
and health 
visitor, when 
I said my 
son hadn’t 
latched on yet
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4.3 Results of economic models
4.3.1 Economic analysis of gastrointestinal infection 
in infants
 
Table 8: Reviews and studies considered for use in calculating  
a summary statistic to inform economic modelling –  
gastrointestinal infection in infants
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used for modelling ✔
whether used as corroborative evidence,
or reasons not used
Systematic Reviews (n=5)
Ip et al, 2007/2009 ✔ Not used – relevant evidence based on Howie 
et al 1990 (see below)
Kramer and Kakuma, 
2002
✔ Not used, but data from the  large Belarus 
study included in this review was used as 
corroborative evidence
Duijts et al, 2009 Does not report a summary statistic Not used
Gutierrez-Castrellon et al, 
2007
Does not report association between 
breastfeeding and gastrointestinal 
infection
Not used
Chak et al, 2009 Outcome is H. Pylori infection in later life, 
not gastrointestinal infection in infancy
Not used
UK studies (n=6)
Howie et al, 1990 ✔ Used as corroborative evidence - larger study 
and more recent data available 
Quigley et al, 2006 ✔ ✔ used for GP cases and general morbidity data
Quigley et al, 2007a/2009 
(same study)
✔ ✔ used for hospitalisation data
Sethi et al, 2001/1999 
(same study)
Small numbers, overlap with Quigley, 
2006
Not used
Fisk et al, 2011 ✔ Used as corroborative evidence – larger study 
with better exposure measurement available
Baker et al, 1998 ✔ Use as corroborative evidence – larger study  
and more recent data available 
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Table 9 below shows the hierarchy of evidence 
used for gastrointestinal infection. For explanation of 
evidence hierarchy, see Section 3.2.3 and Appendix 
2, section 1.5.1. For details of methods and details 
of studies see the relevant data extraction forms 
(Appendix 11).
Table 9: Gastrointestinal infection in infants – hierarchy of 
evidence used for economic modelling. For details of all 
studies see Appendix 11.
 Primary source of evidence Corroborative evidence 
For hospitalisation data
Quigley et al, 2007a
For GP cases and general morbidity
Quigley et al, 2006
 
Howie et al, 1990 
Fisk et al, 2011 
Baker et al, 1998
Kramer and Kakuma, 2002
Calculating the summary statistic to be used for 
economic modelling
The studies identified as primary data sources for 
economic modelling were Quigley et al (2006, 2007a). 
Table 10: Gastrointestinal infection in infants – input  
parameters used in economic analysis
Odds ratios in favour of breastfeeding Incidence Unit costs (2009/10 prices)
Exclusive breastfeeding:
Hospitalisation: 0.39 (0.18-0.85)
GP visits: 0.28 (0.11-0.69) 
Any breastfeeding:
Hospitalisation: 0.52 (0.30-0.87)
GP visits: 0.36  (0.18-0.74)
Hospital admissions: 
17.2/1000 live births
Primary care consultations: 
4,682/100,000 infants <1 year
Hospital admissions: 
Baseline: £989 per admitted child
Lower quartile: £586
Upper quartile: £1,206
Primary care consultation: 
Baseline: £36 per GP consultation
Upper end cost: £53
The figures in parentheses are 95% confidence interval.
Table 10 shows the adjusted odds ratios (ORs) 
for different categories of current infant feeding in 
these studies. In particular, odds ratios are provided 
for the binary comparisons exclusive breastfeeding 
compared with ‘not exclusive breastfeeding’, and 
any breastfeeding compared with ‘no breastfeeding’. 
Note that the results show the ‘effect of breastfeeding 
currently on gastrointestinal infection not the effect 
of any previous breastfeeding which had stopped 
prior to the point of data collection. Full data on input 
parameters may be found in Appendix 12.
UNICEF UK
Preventing disease and saving resources: 
the potential contribution of increasing breastfeeding rates in the UK  41
Any breastfeeding compared with no breastfeeding
The adjusted ORs quantifying the effect of any 
breastfeeding on the current risk of gastrointestinal 
infection ranged between 0.361 and 0.522. 
Exclusive breastfeeding compared with not  
exclusive breastfeeding
The adjusted ORs, quantifying the effect of exclusive 
breastfeeding on current risk of gastrointestinal 
infection, ranged between 0.283 and 0.394. The 
OR for exclusive breastfeeding in the past month, 
compared with not exclusively breastfeeding in 
the past month, is 0.39. The group ‘not exclusively 
breastfeeding in the past month’ will include some 
babies who were never breastfed and others who 
were exclusively breastfed but not within the  
past month. 
1 Small study based on GP cases
2 Large study based on hospital admissions; note that this 
figure is not published
3 Small study based on GP cases
4 Large study based on hospital admissions; note that this 
figure is based on a re-analysis and is not published
Economic analysis of gastrointestinal infection  
in infants
Table 11 provides point estimates of cost-savings 
that could be achieved per annum from reduced 
incidence of gastrointestinal infections and 
the associated treatment costs by increasing 
breastfeeding rates. The data show that 
approximately £1.2 million per annum could be saved 
in hospitalisation costs by increasing the exclusive 
breastfeeding rate at 4 months (7%) to 21% (current 
exclusive breastfeeding rate at 6 weeks). As this 
rate increases further to 45% (the current rate at 1 
week), estimated cost savings in hospitals increase 
to £3.2 million per annum. Higher cost-savings (£5m 
per annum) from hospitalisations could be achieved 
by moving from 7% exclusive breastfeeding at 4 
months to 65% (the breastfeeding rate observed at 
birth). Cost savings from reducing gastroenteritis-
related primary care (GP) consultations in newborn 
children range from £141,000 to £0.6 million per year. 
This table also shows that savings per infant per 
year from both hospital and primary care costs range 
from approximately £1.70 if exclusive breastfeeding 
increased to 21% at four months, to approximately 
£7 if exclusive breastfeeding increased to 65% at 
four months. 
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Policy options Hospitalisation costs Primary care costs Total costs
Estimate 
of cost-
savings per 
year
Potential 
saving per 
infant per 
year
Estimate 
of cost-
savings per 
year
Potential 
saving per 
infant per 
year
Estimate 
of cost-
savings per 
year
Potential 
saving per 
infant per 
year
Policy A1: increase exclusive 
breastfeeding from 7% to 21% 
at 4 months
£1,197,081 £1.52 £141,083 £0.18 £1,338,164 £1.70
Policy A2: increase exclusive 
breastfeeding from 7% to 45% 
at 4 months
£3,249,221 £4.12 £382,939 £0.49 £3,632,160 £4.61
Policy A3: increase exclusive 
breastfeeding from 7% to 65% 
at 4 months
£4,959,337 £6.29 £584,486 £0.74 £5,543,824 £7.03
Policy B1: increase exclusive 
breastfeeding from 0.5% to 7% 
at 6 months
£555,788 £0.70 £65,503 £0.08 £621,291 £0.79
Policy C1: increase ‘any 
breastfeeding’  from 25% to 
48% at 6 months
£1,683,450 £2.14 £232,907 £0.30 £1,916,358 £2.43
Figure 2 illustrates how annual treatment costs 
of gastrointestinal infection fall as the specified 
breastfeeding rate rises. The largest gain occurs 
when current exclusive breastfeeding rates at four 
months are increased to the most optimistic level; 
that is from 7% (current rates) to 65%.
These figures, using our mid-range policy scenario, 
indicate that 3,285 gastrointestinal  infection-related 
hospital admissions and 10,637 GP consultations 
would be averted. 
Sensitivity analyses based on the range of odds 
ratios identified (Appendix 13) suggest that cost 
savings from hospitalisation and GP consultations for 
gastrointestinal infection might range from as low 
as £340,000 to as high as £1.78 million per annum 
if exclusive breastfeeding rates were to increase 
to 21% at four months, and from as low as £1.34 
million to as high as £7.4 million per annum if they 
were to increase to 65% at four months.
Table 11: Estimation of potential savings per year in treating 
gastrointestinal infections in infants less than one year old, due 
to varying increases in different definitions of breastfeeding rates 
(refers to 788,486 infants’ first year of life): showing potential 
savings, £ sterling. For details of all model parameters and 
scenarios, see Section 3.4.2.1 and Appendices 2 and 10.
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Gastrointestinal infection in infants: summary 
Five systematic reviews and six UK studies were 
considered for use in our economic analysis. 
Data from one review and three UK studies were 
used as corroborative evidence. The sources 
considered to best meet the specifications required 
for this outcome were Quigley et al, 2007a (for 
hospitalisation episodes), and Quigley et al, 2006 (for 
primary care consultations).
Economic analysis showed that approximately £1.34 
million per annum could be saved in treatment costs 
in hospital and community by increasing the current 
exclusive breastfeeding rate at four months (7%) to 
21%. Cost savings would increase to £3.6 million per 
annum if the rate at four months were to increase 
to 45%, and £5.6 million per annum could be saved 
annually if the rate were to rise to 65% at four 
months. Using our mid-range policy scenario, 3,285 
gastrointestinal infection-related hospital admissions 
and 10,637 GP consultations would be averted. 
Policy
A0
Policy
A1
Policy
B0
Policy
B1
Policy
C0
Policy
C1
Policy
A2
Policy
A3
£16,000,000
£14,000,000
£12,000,000
£10,000,000
£8,000,000
£6,000,000
£4,000,000
£2,000,000
£0
£13,418,806
£12,221,725
£10,169,585
£8,459,469
£13,974,594
£13,418,806
£13,418,806
£11,735,356
£1,329,091 £1,394,594
£1,329,091
£1,329,091
£1,096,183
£946,151
£744,604£1,188,008
HospitalisationGP visits
Figure 2 Fall in annual cost of treating GI following rises in 
(exclusive or any) breastfeeding (refers to 788,486 infants’ first 
year of life, £ sterling)
UNICEF UK
Preventing disease and saving resources:  
the potential contribution of increasing breastfeeding rates in the UK44
4.3.2 Economic analysis of lower respiratory tract 
infection in infants
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used for modelling ✔
whether used as corroborative evidence,
or reasons not used
Systematic Reviews (n=5)
Ip et al, 2007/2009 ✔ Used as corroborative evidence. More 
appropriate and contemporary UK data available
Bachrach et al, 2003 ✔ Used as corroborative evidence. More 
appropriate and contemporary UK data available 
McNeil et al, 2010 ✔ Used as corroborative evidence. More 
appropriate and contemporary UK data available
Kramer and Kakuma, 
2002 
✔ Used as corroborative evidence. More 
appropriate and contemporary UK data available
Gutierrez-Castrellon et al, 
2007
Does not report association between 
breastfeeding and respiratory tract infection
Not used
Chien and Howie, 2001 Does not report a summary statistic Not used
Duijts et al, 2009 Does not report a summary statistic Not used
UK studies (n=6)
Downham et al, 1976 Old data, exposure unclear Not used
Watkins et al,1979 Old data, adjustment for confounders unclear Not used
Pullan et al, 1980 Old data, exposure unclear Not used
Howie et al, 1990 
and follow up in 
Wilson et al, 1998
✔ ✔ Howie et al used for primary care data on 
exclusive breastfeeding. Wilson et al not 
used (long term follow up data not relevant).
Quigley et al, 2007a/2009 ✔ ✔ Used for hospitalisation data
Fisk et al, 2011 ✔ ✔ Used for primary care data on any 
breastfeeding 
Table 12: Reviews and studies considered for use in calculating 
a summary statistic to inform economic modelling – lower 
respiratory tract infection in infants
UNICEF UK
Preventing disease and saving resources: 
the potential contribution of increasing breastfeeding rates in the UK  45
Calculating the summary statistics to be used for 
economic modelling
Table 13 below shows the evidence used to 
estimate the risk of lower respiratory tract infection 
in infants. For an explanation of evidence hierarchy, 
see Section 3.2.3 and Appendix 2, section 1.5.1. 
For details of methods and specific studies, see the 
relevant data extraction forms (Appendix 11). 
Table 13: Lower respiratory tract infection - hierarchy of 
evidence used for economic modelling. 
 Primary source of evidence Corroborative evidence 
For hospitalisation data
•	 Quigley	et	al,	2007a/2009
For GP cases
•	 Fisk	et	al,	2011	
•	 Howie	et	al,	1990	
Ip et al, 2007
Bachrach et al, 2003
McNeil et al, 2010
Kramer and Kakuma, 2002 
Quigley et al (2007a) quantified the effect of 
breastfeeding currently on respiratory tract infection 
(RTI), but did not estimate the effect of prior 
breastfeeding that had ceased at the point of data 
collection. On the other hand, Fisk et al (2011) and 
Howie et al (1990) took into account the effect of any 
previous breastfeeding on current risk of infection. 
The outcomes of interest were hospitalisation or 
GP consultation for lower respiratory tract infection 
(LRTI), defined variously in the three studies as 
parental report of: ‘a hospital admission for chest 
infection or pneumonia’ (Quigley et al, 2007a, 
Quigley et al, 2009); ‘head cold, accompanied by 
cough or wheeze’ (Howie et al, 1990); and maternal 
report of infant having been ‘diagnosed by a doctor 
with a range of respiratory infections’ (Fisk et al, 
2011). These definitions did not include those with a 
diagnosis of ‘wheezing or asthma’. 
Table 14 below shows the odds ratios and 
confidence intervals derived from Quigley et al 
(2007a/2009) for hospitalisation data, and from Fisk 
et al (2011) and Howie et al (1990) for GP cases; and 
other input parameters used for the model. Full data 
on input parameters is in Appendix 12.
Table 14: Lower respiratory tract infection in infants – input 
parameters used in economic analysis.
Odds ratios in favour of breastfeeding Incidence Unit costs (2009–10 prices)
Exclusive breastfeeding:
Hospitalisation: 0.70 (0.49–0.98)
GP visits: 0.69 (0.47-1.0) 
Any breastfeeding:
Hospitalisation: 0.67 (0.52–0.88)
GP visits: 0.65  (0.43–0.96)
Hospital admissions: 59.1/1000 
live births 
Primary care consultations: 
23,433/100,000 infants <1 year
Hospital admissions: 
Baseline: £1,078 per admitted child
Lower quartile: £749
Upper quartile: £1290
Primary care consultation: 
Baseline: £36 per GP consultation
Upper end cost: £53
The figures in parentheses are 95% confidence interval.
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Economic modelling – lower respiratory tract 
infection in infants
Table 15 provides point estimates of potential 
cost-savings that could be achieved per year from 
reduced treatment costs by increasing breastfeeding 
rates from varying rates and definitions of 
breastfeeding. The data show that approximately 
£2 million per year could be saved in hospitalisation 
costs by increasing the exclusive breastfeeding rate 
at 4 months (7%) to 21% (exclusive breastfeeding 
rate at 6 weeks). As this rate increases further to 
45% (the rate at 1 week), estimated cost savings 
in hospitals increase to £6 million per annum. The 
highest cost-savings per year from hospitalisations 
(£9m) could be achieved by moving from the 
7% exclusive breastfeeding at 4 months to 65% 
(the breastfeeding rate observed at birth). Cost 
savings from reducing LRTI-related primary care 
(GP) consultations in newborn children range from 
£300,000 to £1.2 million per year. 
Table 15 also shows that cost savings per infant per 
year resulting from hospitalisation and primary care 
costs range from approximately £1.40 (if exclusive 
breastfeeding increased to 7% at six months) to 
approximately £12.80 (if exclusive breastfeeding 
increased to 65% at four months). 
Figure 3 summarises how annual treatment costs of 
lower respiratory tract infection in infants would fall 
if the proportion of women sustaining breastfeeding 
were to rise. The largest gains are associated with an 
increase in the prevalence of exclusive breastfeeding 
at 4 months to 65%. 
These figures indicate that using our mid-range 
policy scenarios, 5,916 lower respiratory tract 
infection-related hospital admissions and 22,248 GP 
consultations would be averted. 
Table 15: Estimation of potential savings per year in treating 
LRTI in infants less than one year old, due to increases in varying 
definitions of breastfeeding rates (refers to 788,486 infants’ first 
year of life). For details of all model parameters and scenarios, 
see Section 3.4.2.1 and Appendices 2 and 10.
Policy options Hospitalisation costs Primary care costs Total costs
Estimate 
of cost-
savings per 
year
Potential 
saving per 
infant per 
year
Estimate 
of cost-
savings per 
year
Potential 
saving per 
infant per 
year
Estimate 
of cost-
savings per 
year
Potential 
saving per 
infant per 
year
Policy A1: increase exclusive 
breastfeeding from 7% to 21% 
at 4 months
£2,155,927 £2.73 £295,076 £0.37 £2,451,003 £3.11
Policy A2: increase exclusive 
breastfeeding from 7% to 45% 
at 4 months
£5,851,803 £7.42 £800,920 £1.02 £6,652,723 £8.44
Policy A3: increase exclusive 
breastfeeding from 7% to 65% 
at 4 months
£8,931,700 £11.33 £1,222,457 £1.55 £10,154,157 £12.88
Policy B1: increase exclusive 
breastfeeding from 0.5% to 7% 
at 6 months
£1,000,966 £1.27 £137,000 £0.17 £1,137,966 £1.44
Policy C1: increase ‘any 
breastfeeding’  from 25% to 
48% at 6 months
£4,157,222 £5.27 £586,785 £0.74 £4,744,007 £6.02
UNICEF UK
Preventing disease and saving resources: 
the potential contribution of increasing breastfeeding rates in the UK  47
Policy
A0
Policy
A1
Policy
B0
Policy
B1
Policy
C0
Policy
C1
Policy
A2
Policy
A3
£60,000,000
£50,000,000
£40,000,000
£30,000,000
£20,000,000
£10,000,000
£0
£50,253,643
£48,097,715
£44,401,839
£41,321,943
£51,254,609
£50,253,643
£50,253,643
£46,096,420
£6,651,445 £5,850,525
£6,356,369
£6,788,445
£6,651,445
Hospitalisation
£6,651,445
£6,064,660£5,428,988
GP visits
Sensitivity analyses based on the range of odds 
ratios identified (Appendix 13) suggest that cost 
savings from hospitalisation and GP consultations 
for lower respiratory tract infection might range  
from as little as £441,000 to as much as £4.5 million 
per annum if exclusive breastfeeding rates were 
to rise to 21% at four months. A cost saving of 
between £1.7 million and £17 million per annum 
would be achieved if 65% of women were to 
breastfeed exclusively for the first four months of 
the infant’s life.
Lower respiratory tract infection in infants: summary
Seven systematic reviews and six UK studies were 
considered for use in our economic analysis. Data 
from four of these systematic reviews were used 
as corroborative evidence. The sources considered 
to meet most closely the specifications required for 
modelling were Quigley et al (2007a and 2009) for 
hospitalisation data, and Howie et al (1990) and Fisk 
et al (2011) for primary care consultations. 
Economic analysis showed that approximately  
£2.5 million per annum could be saved in treatment 
costs in hospital and community if the current 
exclusive breastfeeding rate at four months (7%) 
were to increase to to 21%. Cost savings would 
increase to £6.7 million per annum if the rate at 
four months increased to 45%, and £10 million per 
annum could be saved annually by increasing the 
rate to 65% at four months. Using our mid-range 
policy scenarios, 5,916 lower respiratory tract 
infection-related hospital admissions and 22,248  
GP consultations would be averted.
Figure 3: Fall in annual cost of treating LRTI following rises in 
(exclusive or any) breastfeeding (refers to 788,486 infants’ first 
year of life).
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4.3.3 Economic analysis of acute otitis media  
in infants
 
 
Table 16: Reviews and studies considered for use in 
calculating a summary statistic to inform economic  
modelling – acute otitis media in infants (AOM)
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used for modelling ✔
whether used as corroborative evidence,
or reasons not used
Systematic Reviews (n=9)
Ip et al, 2007/2009 ✔ ✔ Same comparison group (never 
breastfed) and outcome (AOM) as 
Fisk 2011 (UK study). Used for data on 
exclusive breastfeeding
McNeil et al, 2010 Same data as Ip, 2007/2009 Not used
Uhari et al, 1996 Included by Ip, 2007/2009 Not used
Campbell, 1996 Does not report a summary statistic Not used
Lubianca Neto, 2006 Does not report a summary statistic Not used
Charlton, 1994 Exposure is smoking, not breastfeeding Not used
Cunningham, 1991 Non-systematic literature review Not used
Wagner, 2009 Outcome is bronchiolitis, not AOM Not used
Rovers, 2006 Outcome is distribution of risk factors for  
otitis media (OM), not association of AOM 
with infant feeding
Not used
UK studies (n=3)
Howie, 1990 Comparison groups and outcome differ 
between these studies and also differ from 
those in Fisk, 2011
Not used
Bennett, 1998 Not used
Fisk, 2011 ✔ ✔ Large study, most recent data, same 
comparison group (never breastfed) and 
outcome (AOM) as Ip2007/2009. Used 
for data on any breastfeeding.
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Calculating the summary statistics to be used for 
economic modelling
Table 17 shows the hierarchy of evidence used for 
acute otitis media (AOM) in infants. For explanation 
of evidence hierarchy, see Section 3.2.3 and 
Appendix 2, section 1.5.1. For details of methods and 
details of studies, see the relevant data extraction 
forms in Appendix 11.
Table 18 below shows the odds ratios and 
confidence intervals derived from Fisk et al (2010) 
for any breastfeeding and from Ip et al (2007) for 
exclusive breastfeeding; and other input parameters 
used for the economic model. Note that only primary 
care data was used, as it is uncommon to admit 
infants to hospital following a clinical diagnosis of 
otitis media (OM), and no data exist on whether or 
not breastfeeding has an effect on hospitalisation for 
otitis media in the UK. Full data on input parameters 
appear in Appendix 12.
Economic modelling: acute otitis media in infants
Table 19 provides point estimates of treatment 
cost-savings that could be achieved each year by 
increasing breastfeeding rates. The data show that 
approximately £0.3 million per annum could be 
saved in GP consultation costs by increasing the 
exclusive breastfeeding rate at 4 months (7%) to 
21% (exclusive breastfeeding rate at 6 weeks). If 
this were to increase further to 45% (the current rate 
at 1 week), cost savings  in GP consultations would 
increase to £0.8 million per annum. Even greater 
savings of £1.2 million per year would be achieved 
if the rate of exclusive breastfeeding at 4 months 
were to increase from the current 7% to 65%, the 
breastfeeding rate currently observed at birth. 
Table 19 also shows that the savings in primary 
care costs for acute otitis media in infants range 
from approximately 16p per infant if exclusive 
breastfeeding rates were to increase to 7% at six 
months, to £1.47 per infant  if exclusive breastfeeding 
rates were to increase to 65% at four months. 
Table 18: Acute otitis media in infants – input parameters 
used in economic analysis
Odds ratios in favour of 
breastfeeding
Incidence Unit costs (2009–10 prices)
Exclusive breastfeeding:
GP visits:  0.50 (0.37-0.70)
Any breastfeeding: 
GP visits: 0.40  (0.21-0.76)
Primary care consultations: 
136/100,000 infants <1 year
Primary care consultation: 
Baseline: £36 per GP consultation
Upper end cost: £53
The figures in parentheses are 95% confidence interval.
Table 17: Acute otitis media in infants - hierarchy of evidence 
used for economic modelling. Details of studies included in 
Appendix 11. 
 Primary source of evidence Corroborative evidence 
For data on any breastfeeding
•	 Fisk	et	al,	2011		
For data on exclusive breastfeeding
•	 Ip	et	al,	2007/09			
None
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Table 19: Estimation of potential savings per year in treating 
acute otitis media in infants less than one year old, due 
to increases in varying definitions of breastfeeding rates 
(refers to 788,486 infants’ first year of life). For details of all 
model parameters and scenarios, see Section 3.4.2.1 and 
Appendices 2 and 10.
Odds ratios in favour of breastfeeding Primary care costs
Estimate of potential cost-savings 
per annum
Potential saving per infant per 
year
Policy A1: increase exclusive 
breastfeeding at 4 months from current 
rate of 7% to 21%
£279,127 £0.35
Policy A2: increase rate of exclusive 
breastfeeding at 4 months to 45%
£757,629 £0.96
Policy A3: increase rate of exclusive 
breastfeeding at 4 months to 65%
£1,156,382 £1.47
Policy B1: increase rate of exclusive 
breastfeeding at 6 months to 7%
£129,595 £0.16
Policy C1: increase ‘any breastfeeding’ 
at 6 months to 48%
£624,728 £0.79
Figure 4 summarises how annual treatment costs of 
infantile AOM fall as the specified breastfeeding rate 
rises. The largest gain occurs when current exclusive 
breastfeeding rates are increased to the most optimistic 
scenario (that is, from current rate of 7% to 65%). 
Figure 4: Fall in annual cost of treating otitis media following 
rises in exclusive or any breastfeeding (refers to 788,486 infants’ 
first year of life, £ sterling). GP consultations only.
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These figures indicate that using the mid-range 
policy scenario, 21,045 acute otitis media-related GP 
consultations would be averted. 
Sensitivity analyses based on the range of odds 
ratios identified (Appendix 13) suggest that primary 
care cost savings related to treatment for otitis media 
might range from as little as £0.17 million to as much 
as £0.35 million if exclusive breastfeeding rates were 
to rise to 21% at four months, or from £0.7 million to 
as much as £1.5 million if the proportion exclusively 
breastfeeding were to increase to 65% at four 
months. Details of the sensitivity analyses are shown 
in Appendix 13. 
Acute otitis media: summary
Nine systematic reviews and 3 UK studies were 
considered for use in our economic analysis. No 
corroborative evidence was identified. The sources 
considered to meet most closely the specifications 
required for modelling were Ip et al (2007) and Fisk 
et al (2011). 
Economic analysis showed that approximately 
£280,000 per annum could be saved in primary care 
costs if the current exclusive breastfeeding rate at 
four months (7%) were to increase to 21%. Cost 
savings would increase to £750,000 per annum 
if the rate at four months increased to 45%, and 
£1.1 million per annum could be saved annually by 
increasing the rate to 65% at four months. Using the 
mid-range policy scenario, 21,045 acute otitis media-
related GP consultations would be averted. 
©
 U
N
IC
E
F 
U
K
/J
en
ni
ng
s
UNICEF UK
Preventing disease and saving resources:  
the potential contribution of increasing breastfeeding rates in the UK52
4.3.4 Economic analysis of necrotising enterocolitis 
(NEC) in infants in neonatal units
Table 20: Reviews and studies considered for use in 
calculating a summary statistic to inform economic  
modelling – necrotising enterocolitis (NEC)
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used for modelling ✔
whether used as corroborative evidence,
or reasons not used
Systematic Reviews (n=5)
Ip et al, 2007/2009 ✔ Used as corroborative evidence.  
Uses older studies.
Barclay, 2007 Exposure not breastfeeding/feeding  
with breastmilk: no comparisons by infant 
feeding group
Not used
McGuire et al, 2003 ✔ Used as corroborative evidence.  
Uses older studies.
Boyd, 2007 Included studies of lower quality than 
Quigley 2007a
Not used
Quigley et al, 2007a ✔ Used as corroborative evidence.  
Uses older studies.
UK studies (n=3)
Lucas et al, 1990 ✔ Used as corroborative evidence – included in 
Quigley et al, 2007
Henderson et al, 2009 ✔ ✔
Leaf et al, 2009 Paper does not report results. Not used
Calculating the summary statistics to be used for 
economic modelling
Table 21 below shows the hierarchy of evidence  
used for necrotising enterocolitis for infants in 
neonatal units. For explanation of evidence hierarchy 
see Section 3.2.3 and Appendix 2, section 1.5.1.  
For details of methods and details of studies see the 
relevant data extraction forms (Appendix 11)
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Table 21: Necrotising enterocolitis - hierarchy of evidence 
used for economic modelling. Details of these studies are 
shown in Appendix 11. 
 Primary source of evidence Corroborative evidence 
Henderson et al, 2009 Ip et al, 2007
McGuire et al, 2003
Quigley et al, 2007a
Lucas et al, 1990
Table 22 below shows the odds ratios and 
confidence intervals used to inform economic 
analysis, derived from Henderson et al (2009), the 
primary source of data identified. Four sources of 
corroborative evidence were also identified. Full data 
on input parameters appear in Appendix 12.
Table 22: Necrotising enterocolitis in infants in neonatal  
units – input parameters used in economic analysis.
Odds ratios in favour of breastfeeding Incidence Unit costs (2009/10 prices)
Any breastmilk: 0.19 (0.05–0.73) NEC cases:
1/100 neonatal admissions
Surgical NEC: 31%
Medical NEC: 69%
Average length of stay: 26.7 days
Surgery: 
Baseline: £1,450 per episode
Lower quartile: £689
Upper quartile: £1,802
Neonatal unit stay:  
Baseline: £618 per bed-day
Lower quartile: £509
Upper quartile: £712
The figures in parentheses are 95% confidence interval.
Economic modelling: necrotising enterocolitis 
Table 23 provides point estimates of treatment cost-
savings that could be achieved each year from by 
increasing breastfeeding/breastmilk feeding rates 
in neonatal units. Approximately £2.3 million per 
year could be saved if the proportion of babies fed 
breastmilk in neonatal units were to increase from 
35% to 50%. A further increase to 75% would 
increase savings in the cost of treating NEC to £6 
million per annum. If the proportion of infants in 
neonatal units fed any breastmilk were to increase 
from the current 35% to 100% the cost of treating 
NEC could fall by as much as £10 million each year. 
Table 23 also shows that the cost of each neonatal 
unit admission could be reduced by between £30 
(if any breastmilk feeding at discharge increased 
to 50%) and £125 (if any breastmilk feeding at 
discharge increased to 100%). 
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 Policy Scenario Total NEC 
cases per 
annum
Total treatment 
costs per annum
Annual cost-savings Potential saving per 
neonatal admission 
Policy D0: current practice 
– any breastmilk feeding 
at discharge: 35%
798 £13,535,618
Policy D1: increase any 
breastmilk feeding at 
discharge to 50%
663 £11,240,325 £2,295,293 £29.02
Policy D2: increase any 
breastmilk feeding at 
discharge to 75%
437 £7,414,836 £6,120,782 £77.39
Policy D3: increase any 
breastmilk feeding at 
discharge to 100%
212 £3,589,347 £9,946,271 £125.75
35% (Policy D0) 50% (Policy D1) 75% (Policy D2) 100% (Policy D3)
£13,535,618 
£16,000,000
£14,000,000
£12,000,000
£10,000,000
£8,000,000
£6,000,000
£4,000,000
£2,000,000
£0
£11,240,325
£7,414,836
£3,589,347
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Figure 5: Fall in annual cost of treating NEC in neonatal units following rises in rate of ‘any breastmilk feeding’ at discharge in neonatal 
units (refers to 79,094 neonatal admissions and 798 NEC cases in 2009/10, £ sterling).
Table 23: Estimation of potential savings per year in treating NEC in infants less than one year old, following increases in the 
rate of ‘any breastmilk feeding’ in neonatal units. For details of all model parameters and scenarios, see Section 3.4.2.1 and 
Appendices 2 and 10.
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Figure 5 summarises how annual treatment costs 
of NEC fall as the specified breastfeeding rate 
rises. The largest gain occurs when the rates for 
‘any breastmilk feeding’ are increased to the most 
optimistic level (that is, from the current rate of 35% 
at discharge, to 100% at discharge).
Sensitivity analyses based on the range of odds 
ratios identified (Appendix 13) suggest that cost 
savings related to treatment for NEC might range 
from a low of £0.61 million to a high of £2.9 million if 
breastfeeding/breastmilk feeding rates at discharge 
increased to 50%, and from £2.6 million to £10 
million if rates rose to 100% at discharge from 
neonatal units. 
We have not considered the economic 
consequences of the deaths caused by NEC in 
terms of QALYS; these would increase the economic 
implications considerably. The mortality rate 
associated with NEC is 15–30% (Lin et al, 2008).
Necrotising enterocolitis in infants in  
neonatal units: summary
Five systematic reviews and three UK studies were 
considered for use in this economic analysis. Data 
from three reviews and one UK study were used 
as corroborative evidence. The source considered 
to best meet the specifications required for this 
outcome was Henderson et al (2009). 
Economic analysis showed that approximately  
£2.3 million per annum could potentially be saved in 
treating necrotising enterocolitis in infants in neonatal 
units by increasing the current rate of breastfeeding/
breastmilk feeding at discharge from neonatal units 
from 35% to 50%. A further increase to 75% could 
increase savings to £6 million per year. Cost savings 
could increase to £10 million per annum if rates at 
discharge increased to 100%. The number of cases 
of NEC would fall from 798 to 212 per annum if all 
babies were breastfed/fed on breastmilk at discharge 
from neonatal units. This rate is currently achieved 
in some European and US units, for example 
Akerstrom et al (2007). This analysis does not include 
the economic consequences of lives lost to NEC, 
which are considerable. 
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4.3.5 Economic analysis of breast cancer in mothers
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used for modelling ✔
whether used as corroborative evidence,
or reasons not used
Systematic Reviews and meta-analyses (n=13)
Ip et al, 2007/2009 ✔ Not used
Collaborative Group on 
Hormonal Factors in Breast 
Cancer et al, 2002
Does not report a summary statistic ✔ Individual patient data meta-analysis, large, 
good quality
Bernier et al, 2000 ✔ Used as corroborative evidence – Collaborative 
Group on Hormonal Factors in Breast Cancer et 
al (2002) better for this purpose (larger, individual 
patient data analysis) 
Lipworth et al, 2000 ✔ Used as corroborative evidence – Collaborative 
Group on Hormonal Factors in Breast Cancer et 
al (2002) better for this purpose (larger, individual 
patient data analysis) 
Ma et al, 2006 ✔ Used as corroborative evidence – Collaborative 
Group on Hormonal Factors in Breast Cancer et 
al (2002) better for this purpose (larger, individual 
patient data analysis)
Yang and Jacobsen, 2008 ✔ Used as corroborative evidence – Collaborative 
Group on Hormonal Factors in Breast Cancer et 
al (2002) better for this purpose (larger, individual 
patient data analysis)
Lee et al, 2008 Does not report numerical differences in 
breast cancer rates by infant feeding groups
Not used
Nagata et al, 1995 Does not report association between 
breastfeeding and breast cancer
Not used
Cohen et al, 2009 Does not report what infants were fed Not used
Wigle et al, 2008 Does not report maternal breast cancer Not used
Martin, 2005d Does not report maternal breast cancer Not used
Lopez-Cervantez et al, 2004 Does not report maternal breast cancer Not used
Schack-Nielsen et al, 2005 Not a systematic review Not used
UK studies (n=6)
UKNCC 1993 ✔ Not used, as only included women age under 36
Lowe and Macmahon, 1970 Old data Not used
Press and Pharoah, 2010 Old data Not used
Martin, 2005d Old data Not used
Perry et al, 2009 No numerical outcomes Not used
Travis et al, 2010 Does not report association between 
breastfeeding and breast cancer
Not used
Table 24: Reviews, meta-analyses and studies considered 
for use in calculating a summary statistic to inform economic 
modelling – breast cancer in mothers.
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Table 25: Breast cancer in mothers - hierarchy of evidence 
used for economic modelling. For details of all studies see 
Appendix 11.
 Primary source of evidence Corroborative evidence 
Collaborative Group on Hormonal Factors 
in Breast Cancer et al, 2002
Bernier et al, 2000
Lipworth et al, 2000
Ma et al, 2006
Yang and Jacobsen, 2008
Calculating the summary statistics to be used for 
economic modelling
Table 25 below shows the hierarchy of evidence 
used for breast cancer in mothers. For explanation of 
evidence hierarchy see Section 3.2.3 and Appendix 
2, section 1.5.1. For details of methods and details 
of studies see the relevant data extraction forms 
(Appendix 11).
Using data from the primary data source 
(Collaborative Group on Hormonal Factors in Breast 
Cancer et al, 2002), and data from the sources 
outlined in Appendix 2, section 2.2.5, parameters 
for the economic modelling were identified. Table 
26 below gives details of the input parameters 
for different lifetime durations of breastfeeding, 
derived from data presented in Collaborative 
Group on Hormonal Factors in Breast Cancer et al 
(Collaborative Group on Hormonal Factors in Breast 
Cancer et al, 2002). Four sources of corroborative 
evidence were also identified. 
Unlike other outcomes examined in this report, this 
outcome applies to the mother’s lifetime duration 
of all breastfeeding, rather than the amount of time 
each baby has been breastfed. Full data on input 
parameters in Appendix 12.
Table 26: Maternal breast cancer – input parameters used in 
economic analysis.
Odds ratios in favour of breastfeeding Incidence Unit costs (2009–10 prices)
Ever breastfeeding vs. never 
breastfeeding: 0.96 (0.92–0.99)
Breastfeeding for <6 months v never: 
0.98 (0.95–1.01)
Breastfeeding for 7-18 months v never: 
0.94 (0.91-0.97)
Breastfeeding for 18+ months v never: 
0.89 (0.84–0.94)
Breast cancer cases: 
Lifetime incidence of 12,500/100,000 
population (that is a lifetime risk of 
1 in 8)
Breast cancer average:
Baseline: £11,726 per case
Upper end cost: £16,260
The figures in parentheses are 95% confidence interval.
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Economic modelling: breast cancer in mothers
The expected impact on the costs of treating 
women with breast cancer following changes in 
breastfeeding patterns are presented as potential 
cost-savings. 
Table 27 provides point estimates of the reduced 
costs of treating maternal breast cancer in the 
UK if breastfeeding rates increased from current 
levels. Results show that over £15 million per 
313,817 first-time mothers could be saved in breast 
cancer treatment costs over their lifetime, if half 
of the women who currently do not breastfeed 
were enabled to breastfeed for up to six months 
in their lifetime. If the proportion of those ‘never-
breastfeeding’ were halved, and 32% of women 
were enabled to breastfeed for a lifetime total of 
7–18 months, the predicted savings from breast 
cancer would be over £21 million per 313,817 first- 
time mothers, over their lifetime. Cost savings would 
rise to almost £28 million per 313,817 first-time 
mothers over their lifetime if the proportion never 
breastfeeding (32%) were halved (to 16%) and the 
number of parous women breastfeeding for 18+ 
months were doubled from 16% to 32%. Policy 
E1 aims at halving the percentage of mothers who 
‘never breastfeed’ (from 32% to 16%) and increasing 
the number of mothers who breastfeed for ≤6 
months over their lifetime by 16 percentage points 
(from 36% to 52%).
Table 27 also shows the number of cases of breast 
cancer that could be avoided under different policy 
scenarios per 313,817 first time mothers over their 
lifetime. These range from 627 if 52% of women 
could be supported to breastfeed for up to six months 
in their lifetime, to 1,136 if 32% of women could be 
enabled to breastfeed for more than 18 months in 
their lifetime. 
As well as the financial savings from reduced 
incidence of disease, it is important to capture health 
impacts that result from the avoidance of breast 
cancer. These are quantified in terms of QALYs 
that consider life years gained and improvements 
in quality of life that might be gained as a result of 
avoiding breast cancer (National Institute for Health 
and Clinical Excellence, 2008 – see Appendix 2, 
section 2 for explanation. Table 27 estimates that 
371 QALYs would be gained across the lifetime 
of 313,817 first-time mothers, if half of those who 
are not breastfeeding currently were supported to 
breastfeed for up to six months in their lifetime. If the 
current ‘never breastfeeding’ rate were halved and 
the breastfeeding rate for 7–18 months increased 
to 32%, the predicted annual QALY gains would be 
about 512. The scenario with the highest potential 
QALYs gained (673 QALYs per 313,817 first time 
mothers over their lifetime) could be achieved by 
moving from 32% ‘never breastfeeding’ to a position 
that halves this rate and doubles the number of 
women breastfeeding for 18+ months from 16% to 
32%. At £20,000 per QALY threshold, these QALY 
gains, when combined with savings from treatment 
costs, offer an incremental benefit of about £23 
million, £31 million and £41 million per 313,817 first-
time mothers over their lifetime, respectively.
Economic gains would, of course, be greater if 
breastfeeding rates increased further.
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Table 27: Estimated potential benefits from reducing maternal 
breast cancer (refers to a cohort of 313,817 primiparous 
women* over their lifetime). Current policy scenarios are fully 
described in Section 3.4.2.1 and Appendices 2 and 10.
Policy options Expected 
breast 
cancer 
cases over 
cohort 
lifetime 
Cancer 
cases 
avoided 
over cohort 
lifetime 
(relative to 
Policy E0)
Incremental 
QALYs 
gained over 
cohort life 
time
Treatment 
costs saved 
over cohort 
life time
Value of 
QALYs 
gained 
over cohort 
lifetime
Incremental 
benefit** 
over cohort 
lifetime
Policy E0: current rates (that 
is, 32% never breastfeed; 
36% ≤6 months; 16% 7-18 
months; 16% 18+ months)
39,227 -    -
Policy E1: Half of never 
breastfed women breastfeed 
for ≤ 6 months (that is, 16% 
never breastfeed; 52% ≤6 
months; 16% 7–18 months; 
16% 18+ months)
38,600 627 371 £15,336,495 £7,424,663 £22,761,158
Policy E2: Half of never 
breastfed women breastfeed 
for ≤ 18 months (that is, 16% 
never breastfed; 36% ≤6 
months; 32% 7–18 months; 
16% 18+ months)
38,362 865 512 £21,171,335 £10,249,410 £31,420,745
Policy E3: Half of never 
breastfed women breastfeed 
for 18+ months (that is, 16% 
never breastfeed; 36% ≤6 
months; 16% 7–18 months; 
32% 18+ months)
38,091 1136 673 £27,800,286 £13,458,600 £41,258,886
*Estimated by multiplying the number of live births (788,486) in the UK 
(ONS 2009) by proportion of primiparous women (39.8%) in the UK 
(EURO-PERISTAT Project, 2008).
**Incremental benefit defined as the difference in total loss (that is, 
sum of treatment costs and the value of QALYs lost) between baseline 
(Policy E0) and the new scenario (Policy E1 or E2 or E3).  
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Figure 6: Fall in number of breast cancer cases and 
corresponding incremental benefit values assuming different 
rises in breastfeeding rates (refers to 313,817 primiparous 
women; time horizon: lifetime; £ sterling).
Sensitivity analyses based on the range of odds 
ratios identified (Appendix 13) suggest that lifetime 
cost savings related to treatment for breast cancer 
might range from £6 million to a high of £40 million 
for an annual cohort of 313,817 primiparous women 
if the number of mothers ‘never breastfeeding’ 
reduced to 16%, and 52% of mothers were 
supported to breastfeed for up to 6 months in their 
lifetime; and from £19 million to £64 million for a 
cohort of 313,817 primiparous women if the number 
of women ‘never breastfeeding’ reduced to 16%, 
and 32% of women were supported to breastfeed 
for 18+ months in their lifetime.
Breast cancer in mothers: summary
Thirteen systematic reviews and meta-analyses 
and six UK studies were considered for use in this 
economic analysis. Data from four reviews were used 
as corroborative evidence. The source considered 
to meet most closely the pre-set requirements for 
modelling this outcome was a large meta-analysis 
of individual patient data (Collaborative Group on 
Hormonal Factors in Breast Cancer et al, 2002). 
Economic analysis showed that lifetime benefits are 
approximately £15 million saved in the treatment 
of breast cancer, 627 breast cancer cases avoided, 
and 371 QALYs gained per annual cohort of around 
313,000 women giving birth to their first baby 
(equivalent to an incremental benefit of around 
£23 million), by reducing the proportion of women 
who never breastfeed from 32% to 16% whilst 
supporting 52% of women to breastfeed for a total 
lifetime period of 6 months. 
Lifetime cost savings to the health service could be 
increased to around £21 million per annual cohort of 
around 313,000 women, by reducing the proportion 
of women who never breastfeed to 16%, whilst 
supporting 32% of women to breastfeed for  up to  
18 months of their lives. In such a scenario, 865 
breast cancer cases would be avoided, and 512 
QALYs gained, equivalent to a incremental benefit of 
over £31 million per annual cohort of 313,000 women 
over their lifetime.
Figure 6 summarises how the number of maternal 
breast cancer cases fall (and therefore incremental 
benefit rises) as the rate of women never-
breastfeeding declines. The scenario with the largest 
gain would be if the number of women who never-
breastfeed was to be halved and the breastfeeding 
rate for 18+ months were doubled. 
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4.4 Summary of costs of all five economic models
Table 28 to Table 30 below show the estimated 
annual cost savings, for each of the three main 
policy scenarios, of the five diseases for which 
we developed economic models. The four acute 
diseases in infants would result in short-term savings 
from treatment costs, while savings from avoiding 
breast cancer cases would accrue over the lifetime 
of each annual cohort of first time mothers; as would 
the breast cancer-related QALYs gained. 
Using the least optimistic policy scenarios (increasing 
exclusive breastfeeding to 21% at four months, 
and 35% of babies breastfeeding at discharge from 
neonatal units), a total of around £6.37 million could 
be gained annually by avoiding the costs of treating 
the four acute diseases in infants. A further £15 
million would be saved from the costs of treating 
breast cancer over the lifetime of each annual cohort 
of first-time mothers if 16% of women breastfed for 
18+ months in their lifetime, and the value of breast-
cancer QALYs gained for each annual cohort would 
be around £7.4 million. 
Using the most optimistic policy scenarios 
(increasing exclusive breastfeeding to 65% at four 
months, and 100% of babies breastfeeding at 
discharge from neonatal units), a total of around 
£26.8 million could be gained annually by avoiding 
the costs of treating the four acute diseases in 
infants. A further £28 million would be saved from 
the costs of treating breast cancer over the lifetime 
of each annual cohort of first-time mothers if 32% of 
women breastfed for 18+ months in their lifetime, 
and the value of breast-cancer QALYs gained for 
each annual cohort would be around £13.4 million. 
Even the most optimistic policy scenarios were set 
at realistic levels, and have taken into account rates 
achieved in other European countries – for example, 
Sveriges officiella statistik och Socialstyrelsen (2009) 
and Lande et al (2003). Greater economic gains 
would be made were rates to exceed these levels. 
Table 28: Results of economic models of acute disease in 
infant – estimated annual savings from avoiding costs of 
disease, UK: Savings from costs of treatment for all diseases.
Acute disease in infants Annual savings from 
least optimistic policy 
scenarios
Annual savings from  
mid-level policy scenarios
Annual savings from 
most optimistic policy 
scenarios
Gastrointestinal infection in 
infants
£1.34 million £3.6 million £5.54 million
Respiratory tract infection 
in infants
£2.45 million £6.7 million £10.15 million
AOM in infants £279,000 £757,000 £1.16 million
NEC, infants in neonatal 
units
£2.3 million £6.12 million £10 million
Total annual savings from 
acute disease in infants
£6.37 million £17.18 million £26.85 million
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Table 29: Results of economic model of breast cancer 
in mothers – estimated savings in treatment costs from 
avoiding costs of disease over the lifetime of an annual 
population of 313,817 primiparous women, UK.
Breast cancer in mothers Cost savings over lifetime 
of each annual cohort 
from least optimistic 
policy scenarios
Cost savings over lifetime 
of each annual cohort 
from mid-level policy 
scenarios
Cost savings over lifetime 
of each annual cohort 
from most optimistic 
policy scenarios
Breast cancer in mothers £15 million £21 million £28 million
Table 30: Results of economic model of breast cancer in 
mothers – estimated breast cancer cases averted with 
number and value of lifetime QALYs gained over the lifetime 
of an annual population of 313,817 primiparous women, UK 
(valued at £20,000/QALY).
Breast cancer in mothers Least optimistic policy 
scenarios
Mid-level policy scenarios Most optimistic policy 
scenarios
Breast cancer cases 
averted
627 865 1136
QALYs gained 371 512 673
Value of QALYS gained  
per annual cohort
£7.4 million £10.2 million £13.4 million
These cost savings should be set against the costs 
required to increase breastfeeding rates; this is 
discussed in Section 5.3. 
4.5 Outcomes where a quantified approach  
was not possible
Our reviews of disease and developmental 
outcomes identified a number of conditions 
associated with ‘not breastfeeding’ where the 
evidence is of good quality, and which have 
potentially large economic consequences, but 
where these could not be feasibly quantified. 
The reasons included uncertainty about the size 
of association between breastfeeding and the 
condition, an absence of reliable evidence on the 
economic impact of the condition, the complexity of 
the economic modelling exceeding the scope of this 
study, and a substantial part of the burden of costs 
falling on sectors other than the health services. The 
limitations of current evidence are similar to other 
public health questions.
It is nevertheless important that the economic 
impacts associated with these outcomes are not 
overlooked. Although there is significant uncertainty 
about the proportion of treatment costs in these 
conditions that might be saved by increasing the 
prevalence of breastfeeding, the amounts might 
significantly outweigh those estimated in earlier 
sections, in part because costs are accrued over an 
individual’s whole life. 
Throughout this section on narrative analyses, costs 
have not been discounted.
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Table 31: Reviews and studies considered to identify 
optimum evidence – cognitive outcomes.
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used for modelling ✔
whether used as corroborative evidence,
or reasons not used
Systematic Reviews (n=4)
Ip et al, 2007/2009 ✔ Not used: included studies heterogeneous 
with respect to exposure (breastfeeding/
breastmilk feeding) and outcome (what 
outcomes were measured, when and how), 
and are not from the UK.
Horta et al, 2007 ✔ Not used: same data included in more 
recent review (Ip et al)
Anderson et al, 1999 ✔ Not used: same data included in more 
recent review (Ip et al)
Drane 2000 ✔ Not used: same data included in more 
recent review (Ip et al)
UK studies (n=5)
Quigley et al, 2012 ✔ ✔ Large study, reports term and pre-term 
infant separately
Iacovou and Sevilla-Sanz, 
2010
✔ Does not report term and preterm infants 
separately. Relevant good quality evidence  
to consider
Holme et al, 2010 Outcome reporting not appropriate. Large 
proportion of smokers in sample. 
Not used.
Rodgers, 1978 Older data Not used
Lucas et al, 1984 No comparisons between infants who did 
and did not receive human milk.  
Not used
4.5.1 Cognitive outcomes: the economic 
consequences associated with not 
breastfeeding
Evidence identified: cognitive outcomes
Table 31 below shows the studies considered for 
use in our economic analysis of cognitive outcomes.
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Table 32 below shows the sources with the most 
relevant evidence for the UK. We identified one 
primary source of data (Quigley et al, 2012), and one 
other source of relevant good quality evidence.
Table 32: Summary of evidence used for cognitive out-
comes.
 Primary source of evidence Other studies with relevant good 
quality evidence
Quigley et al, 2012 Iacovou et al, 2010 
Table 33: Summary of data from primary source of evidence, 
cognitive outcomes (full results shown in Appendix 11).
Primary source of evidence Summary of relevant findings
Quigley et al, 2012 “After adjusting for confounders, there was a significant difference in mean score 
between those breastfed and those never breastfed: 
•	 in	term	children,	a	2-point	increase	in	score	for	picture	similarities	(if	breastfed	
for ≥4 months) and naming vocabulary (if breastfed for ≥6 months)
•	 in	preterm	children,	a	4-point	increase	for	naming	vocabulary	(if	breastfed	for	
≥4 months) and picture similarities (if breastfed for ≥2 months) and a 6-point 
increase for pattern construction (if breastfed for ≥2 months) 
These differences suggest that breastfed children will be 1–6 months ahead of 
children who were never breastfed.”
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Narrative assessment of the impact of not 
breastfeeding on cognitive outcomes
Whilst earlier reviews were sceptical about the 
quality of the evidence and in particular the ability 
to control for confounding variables (Ip et al, 2007), 
there is a growing body of well-designed studies that 
explore the association between breastfeeding and 
cognitive outcomes. They conclude that increasing 
both the proportion of infants who are breastfed and 
the duration of breastfeeding are associated with 
improved cognitive outcomes (Quigley et al, 2012; 
Iacovou and Sevilla-Sanz, 2010). 
Accurately estimating the effect of breastfeeding 
on cognitive and related outcomes is inherently 
challenging. It demands: access to longitudinal 
cohort data over a significant period; accurate, 
preferably prospective, measurement of feeding 
behaviours; and comprehensive data on a number 
of potential confounders, most notably measures 
of maternal cognitive ability. Most evidence points 
to a positive correlation with breastfeeding, but the 
magnitude of the impact remains uncertain. One 
reason for this is the low prevalence of exclusive 
breastfeeding in developed countries: most children 
tested will have received some breastmilk substitute 
even if described in the studies as breastfed. This 
may dilute the potential effect of breastfeeding. 
Another methodological challenge is the 
inconsistency in the methods used to measure 
cognitive and developmental abilities in the absence 
of an internationally accepted approach. Studies 
have measured outcomes as varied as IQ, test 
scores in reading, writing and maths, naming 
vocabulary, and pattern construction. A number of 
international studies have reported improvements 
in IQ levels of 5–6 points in children who are 
breastfed compared to those who are not (Kramer 
et al, 2008; Oddy et al, 2003). A meta-analysis 
by Anderson et al (1999) indicates that these 
differences persist once confounding factors, such 
as maternal age, education and IQ, are taken into 
account. Meta-analysis is complicated by differing 
approaches to measuring cognitive outcomes and 
different definitions of breastfeeding. However, 
the Anderson study indicates that an unadjusted 
increment of approximately five points resulting 
from breastfeeding is reduced to around three points 
after adjustment for confounders and, importantly, 
remains statistically significant. 
The most recent study from the UK adopted a 
battery of measures, including the British Ability 
Scales (BAS) which assess vocabulary, pictorial 
reasoning and spatial abilities (Quigley et al, 2012). 
These suggest that the mean scores for all sub-
scales increased with duration of breastfeeding even 
after adjustment for confounders. The effects were 
even more marked in children born pre-term. 
Previous commentators have recognised that effects 
on cognitive outcomes are associated with economic 
consequences (Phelps, 2011), although to our 
knowledge there have been no attempts to quantify 
these in financial terms (Phelps, 2011). Whilst the 
gains in cognitive ability reported above might be 
considered to be relatively modest, these can have 
significant and long-lasting financial impacts as 
well as broader societal impacts. The most obvious 
outcome is an impact on educational attainment 
levels that, in turn, is associated with an impact on 
lifetime earnings. In order to estimate the magnitude 
of this effect, one can draw on evidence from the 
field of environmental economics. 
A number of studies have sought to identify the 
economic impacts of environmental pollutants that 
might impact on the cognitive development of 
children. The most notable body of evidence relates 
to legislation to control exposure to harmful levels 
of lead in the environment in the United States. 
Needleman and Gatsonis (1990) undertook a rigorous 
meta-analysis of the evidence on lead exposure and 
the IQ of children, and concluded that there was 
strong support for the hypothesis that exposure to 
low levels of lead can impair children’s IQ. Grosse 
et al (2002) estimate that legislation to reduce 
blood lead levels in the United States between the 
late 1970s and the late 1990s led to an increase in 
average IQ levels of 2.2–4.7 points. Furthermore, 
these authors went on to estimate the financial 
effects of these changes, arguing that for each one 
point increase in IQ, worker productivity increases 
by between 1.76–2.38% (base case assumed to be 
2%). Applying this to estimated lifetime earnings 
suggested that a one point increase in IQ would 
result in an improvement in lifetime earnings of 
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approximately US$14,500 (range US$12,700–17,200) 
and that legislation to reduce exposure to lead 
would result in an increase in lifetime earnings of 
approximately US$56,100 (note all figures reported in 
US$ prices in year 2000).
To put these into a UK context, estimates from 
the Learning and Skills  Council in 2007 suggest 
that lifetime earnings range from £873,392 for an 
individual with no formal educational qualifications to 
£1,819,792 for an individual with a degree or higher 
qualification. Table 34 below reports the findings 
of applying the earnings with IQ ratio adapted by 
Grosse et al (2002) to these estimates of lifetime 
earnings. We used a conservative assumption, 
derived from the studies included in this section,  
that breastfeeding for a minimum of 2–3 months 
leads to an increment of 1–2 points in IQ compared 
to not breastfeeding.
Table 34: Estimated impact of a 1–2 point increase in IQ 
on lifetime earnings (2007 prices).
Assumed increase in IQ Estimated increment to lifetime earnings (2007 prices)
No formal educational qualifications Degree or higher qualification
1 point increase in IQ £17,468 £36,396
2 point increase in IQ £34,936 £72,792
Our estimates suggest that breastfeeding for 
a minimum of 2–3 months might add between 
£17,000 and £72,000 to lifetime earnings. More 
prolonged breastfeeding is expected to lead to 
greater increments in IQ levels as studies included 
here have found evidence of dose-response effect. 
These estimates are presented at an individual level; 
scaling them to a population level would lead to more 
marked potential gains to the economy as a whole. 
We have considered the economic implications 
of this at a national level, using very conservative 
assumptions based on the evidence presented in 
this section, as follows:
UNICEF UK
Preventing disease and saving resources: 
the potential contribution of increasing breastfeeding rates in the UK  67
Table 35: Estimated economic implications of adverse 
cognitive effect in the UK. 
Number of live births in 2009 – 
adjusted for neonatal (28 days) 
mortality
788,486 (ONS)
% never breastfed 19% (Infant Feeding Survey 2010)
Number never breastfed 149,886
Adverse cognitive effect resulting  
from this
2 IQ points (assumed as above)
Lifetime income losses that result  
from adverse cognitive effect
£34,936 per individual never breastfed
If the proportion of never breastfeed infants were 
to decrease by only 1%, from 19% to 18%, the 
resultant estimated impact would be: 
•	 7,959 fewer children who experience a 
reduction in potential IQ , resulting in 
•	 circa £278 million gains in economic productivity 
These economic losses are projected solely on the 
number of births in the 2009 birth cohort and would 
be cumulative annually, suggesting that costs over a 
longer period could be substantial. This scenario has 
only considered decreasing the proportion of never 
breastfed infants by one percentage point. Increasing 
the duration of breastfeeding for those who start to 
breastfeed would bring additional benefits. 
Whilst impact on lifetime earnings is clear, other 
financial and non-financial impacts also need to be 
considered. Some studies have suggested that lower 
incidence and shorter durations of breastfeeding 
might be associated with greater prevalence of later 
behavioural problems compared to more prolonged 
breastfeeding, for example Heikkilä et al (2011). 
These may have further consequences for a child’s 
schooling as well as family relationships and social 
functioning, requiring more intensive teaching and 
leading to exclusion from activities. Establishing 
a causal link between breastfeeding and such 
outcomes is challenging, but changing early feeding 
behaviours at least has the potential to modify an 
individual’s social skills, personal development and 
family life. This should be considered in the context 
of other early years interventions that have long 
term impact on children and families (Heckman and 
Masterov, 2004; Sinclair, 2007). 
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4.5.2 Sudden Infant Death Syndrome (SIDS): the 
economic consequences associated with not 
breastfeeding
Evidence identified: Sudden Infant Death Syndrome
Table 36 below shows the studies considered for 
use in our economic analysis of SIDS.
Table 36: Reviews and studies considered to identify 
optimum evidence - Sudden Infant Death Syndrome.
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used ✔
or reasons not used
Systematic Reviews (n=1)
Hauck et al, 2011 ✔ Good quality meta-analysis. Deals 
with confounders. The effect size 
is strengthened by duration of 
breastfeeding (as measured at 2 months) 
and exclusivity. 
✔
UK studies (n=2)
Tappin et al, 2005 Examined sleeping surface. Infant feeding 
not defined or measured.
Not used
Blair et al, 2006 Examined sleeping position. Infant feeding 
not measured/defined.
Not used
Table 37 below shows the most relevant sources  
of data for the UK. We identified one primary source 
of data: a good quality meta-analysis by Hauck et  
al (2011).
Table 37: Summary of evidence used for Sudden Infant 
Death Syndrome.
 Primary source of evidence Alternative sources of relevant 
evidence
Hauck et al, 2011 None
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Table 38: Summary of data from the primary source of 
evidence – Sudden Infant Death Syndrome. Full details 
appear in Appendix 11. 
Primary source of evidence Relevant data 
Hauck et al, 2011 For infants who received any amount of breastmilk for any duration, the univariable 
SOR was 0.40 (95% confidence interval [CI]: 0.35–0.44), and the multivariable SOR 
was 0.55 (95% CI: 0.44–0.69).
For any breastfeeding at 2 months of age or older, the univariable SOR was 0.38  
(95% CI: 0.27–0.54).
The univariable SOR for exclusive breastfeeding of any duration was 0.27  
(95% CI: 0.24–0.31).
Narrative assessment of the impact of not 
breastfeeding on SIDS
Of all the outcomes associated with not 
breastfeeding, SIDS might be considered the most 
catastrophic. The paradox is that from a purely 
financial perspective, SIDS is one of the least costly 
outcomes. A ‘burden of illness’ approach would treat 
SIDS as an event associated with relatively modest, 
one-off costs to the NHS. This is revealed in the unit 
cost allocated to individuals who are ‘dead on arrival’ 
at hospital, amounting to just £87 in the 2009–10 
NHS Reference Costs. Whilst there may be some 
additional costs (for example, transportation, death 
certification and bereavement support), the overall 
cost of an infant death to the health service is very 
low when compared with that associated with a 
chronic illness of lifelong duration. 
It is inappropriate, however, to focus on monetisation 
given the profound effect that SIDS has on families 
following the loss of their baby  and so a broader 
perspective on SIDS has been taken. These indirect 
costs might be summarised as: 
•	 The emotional burden (suffering, loss of  
well-being) on family members
•	 Loss of life years as a consequence of 
premature death 
•	 Loss of lifetime productivity to the economy 
associated with premature death 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•	 Financial impact on family members (for 
example, as a result of lost productivity  
through grief) 
•	 Health and social care costs associated with the 
need to support the family. 
There are methods available to estimate these 
costs. Individuals can be viewed economically as 
‘human capital’; that is, a means of production that 
can be economically valued as such. This approach 
does not, however, account for pain and suffering 
associated with an outcome such as SIDS, and also 
fails to allow for societal preferences to avoid such 
events. These aspects are better addressed by 
adopting techniques such as “willingness to pay” 
estimation that are typically adopted to examine the 
value placed on averting events such as SIDS. 
This technique involves asking groups how much 
they would be willing to pay (hypothetically) to 
reduce the risk of SIDS from x to y. Whilst the 
questions can be developed in such a way to elicit 
accurate and sensible responses, ultimately these 
techniques rely on the hypothetical, as individuals 
are aware that they will not be required to make any 
actual payment. As such, there may be the potential 
for individuals to overstate their willingness to pay, 
particularly for the avoidance of highly emotive 
events such as infant deaths. Such techniques are 
infrequently used in economic studies of health care 
in the UK. 
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There are relatively few studies that have sought 
to quantify the impact of SIDS in relation to infant 
feeding. In their analysis of the burden of sub-
optimal breastfeeding, (Bartick and Reinhold, 2010) 
estimated the cost of a death at US$10.56 million, 
referring to a previous study (Weimer, 2001) that 
adopted a ‘labour-market’ approach based on the 
higher wages demanded for riskier jobs. The same 
value was applied to infant deaths resulting from 
SIDS or NEC, and to deaths in later life, for example 
as a result of type 1 diabetes. 
Given the paucity of evidence, alternative approaches 
to valuing the impact of breastfeeding on SIDS 
are required. Health technology assessments 
conducted by the National Institute of Health and 
Clinical Excellence adopt a threshold value for 
an additional quality adjusted life year (QALY) of 
between £20,000–£30,000 (National Institute for 
Health and Clinical Excellence, 2008). Assuming 
that this is a fair reflection of the value that society 
places on a life year in full health, and that this value 
does not discriminate by age, this figure could be 
applied to value loss of life as a result of SIDS. Taking 
a mean life expectancy at birth of around 80 years 
and average population quality of life of around 0.8, 
a newborn could be expected to accrue 64 years of 
life in full health. Premature death during the first full 
year of life would thus result in a loss of between 
£1.28 million–£1.92 million (undiscounted). 
Another option might be to apply Her Majesty’s 
Treasury value of £1,585,510 million per fatality 
avoided (Department for Transport, April 2011). This 
figure was originally devised for use in studies of 
transport safety, but has been presented in Treasury 
guidance intended to inform the evaluation of public 
sector programmes more generally. 
We have applied these costs to estimate the 
economic implications of SIDS at a national level, 
using very conservative assumptions (Table 39). 
To illustrate the impact that this might have at 
national level; based on the studies included in this 
section, it is a reasonable expectation that even a 
modest increase in exclusive breastfeeding for more 
than two months could result in a 1% reduction in 
the incidence of SIDS. If this was the case, at least 
three cases of SIDS would be avoided, preventing a 
monetary loss of approximately £4.7 million as well 
as avoiding the profound consequences for families.
Table 39: Illustrative example of the scale of the 
economic implications of SIDS in the UK.
Number of SIDS* 2009 279 in England & Wales (ONS, 2011)
Extrapolated to UK population 315 (Iacovou et al, 2010) 
Rate of SID 0.4/1,000 live births (ONS)
Value of statistical life £1,585,510 (Department for Transport, April 2011)
Value of lives lost to SIDS £499,435,650
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4.5.3 Childhood obesity: the economic 
consequences associated with not 
breastfeeding
Evidence identified: childhood obesity
Table 40 below shows the studies considered for 
use in our economic analysis.
Table 40: Reviews and studies considered to identify 
optimum evidence – childhood obesity.
Reviews and studies 
identified in searches
Considered for modelling ✔
or reasons not considered
Used ✔, whether used as other source of 
relevant evidence, or reasons not used
Systematic Reviews (n=8)
Horta et al, 2007 ✔ ✔
Ip et al, 2007/2009 Does not report a summary statistic Not used
Arenz et al, 2004 Finds evidence of association Not used - included in Horta et al
Owen et al, 2005a Finds evidence of association Not used - Included in Horta et al
Owen et al, 2005b Finds no evidence of association Not used - included in Horta et al
Huang, 2009 Not a systematic review, does not report a 
summary statistic
Not used
Smith and Harvey, 2010 Economic evaluation for Australia with 
effectiveness data based on Horta 2007
Not used
Harder et al, 2005 Lack of control for confounders Not used
UK studies (n=6)
Wilson et al, 1998 ✔ Used as other source of relevant evidence: 
exposures, control for confounders, 
outcome measures and outcomes differ 
Armstrong and Reilly, 
2002
✔ Used as other source of relevant evidence: 
exposures, control for confounders, 
outcome measures and outcomes differ
Parsons et al, 2003 Old data – offspring of 1958 birth cohort Not used
Li et al, 2003 ✔ Used as other source of relevant evidence: 
exposures, control for confounders, 
outcome measures and outcomes differ
Reilly et al, 2005 ✔  Used as corroborative evidence: exposures, 
control for confounders, outcome measures 
and outcomes differ
Griffiths et al, 2009 Looked at weight gain rather than obesity Not used
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 Primary source of evidence Other sources of relevant evidence
Horta et al, 2007 Armstrong and Reilly, 2002; Li et al, 2003; 
Reilly et al, 2005; Wilson et al, 1998 
Primary source of 
evidence
Summary of relevant findings
Horta et al, 2007 From 39 estimates of the effect of breastfeeding on prevalence of overweight/
obesity: in a random-effects model, breastfed individuals were less likely to be 
considered as overweight and/or obese, with a pooled odds ratio of 0.78  
(95% CI: 0.72–0.84). Control for confounding, age at assessment, year of 
birth, and study design did not modify the effect of breastfeeding. Because a 
statistically significant protective effect was observed among those studies that 
controlled for socio-economic status and parental anthropometry, as well as 
with >1,500 participants, the effect of breastfeeding was not likely to be due to 
publication bias or confounding.’
Narrative assessment of the impact of not 
breastfeeding on childhood obesity
The increasing prevalence of obesity in the UK 
is widely recognised. The most recent data on 
childhood obesity in England are derived from the 
National Child Measurement Programme conducted 
in 2010 (Department of Health, 2011). This suggests 
that 31% of boys and 29% of girls age 2–15 are 
obese or overweight. In younger children age 4–5, 
obesity prevalence was just below 10%. There is a 
recognition that many children who are obese will 
continue to be so in adulthood though the exact 
proportion is not clear. The Foresight report Tackling 
Obesities (McPherson et al, 2007) estimates that a 
child who is obese age 1–2 years is 30% more likely 
to be obese as an adult. This ratio increases markedly 
with age and the degree of obesity. Although there 
are signs that the rate of increase in childhood obesity 
is reducing (Stamatakis et al, 2010), the prevalence of 
adult obesity in future generations is expected to rise 
as a consequence of trends in childhood. 
The impact of obesity on public expenditure has 
been well documented. The cost of obesity and 
related conditions to the NHS is estimated to be in 
excess of £4 billion (Department of Health, 2008) 
although this represents only part of the total cost 
to society as a whole. The Foresight report (2007) 
estimates that current trends in obesity, if not 
arrested, would cost the UK economy £50 billion by 
2050. The direct costs of treating obesity, for example 
through pharmacological or surgical approaches, 
are actually relative modest. Evidence from the 
Counterweight programme identified that obesity 
increases prescription costs for obesity and related 
conditions as well as GP consultations (McQuigg 
et al, 2008). However, the real economic impact 
of obesity is associated with the increased risk of 
developing weight-related conditions over a lifetime. 
For example, obesity is associated with an increased 
risk of developing type 2 diabetes, hypertension 
and coronary heart disease (McPherson et al, 2007). 
There is also an increased risk of certain cancers, 
including colon cancer and breast cancer (McPherson 
et al, 2007). Obesity is also associated with increased 
risk of musculoskeletal disease and depression 
(McPherson et al, 2007).
Table 42: Summary of data from the primary source of evidence –  childhood obesity. Full details appear in Appendix 11.
Table 41: Summary of evidence used for childhood obesity.
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Quantifying the effect of infant feeding behaviour 
on obesity and its associated costs is challenging. 
Obesity is affected by a number of factors, and 
controlling for confounding variables is a particular 
challenge: for examples of this debate, see Brion et al 
(2011), Daniels and Adair (2005), Owen et al (2005).
Much evidence suggests that not breastfeeding is 
associated with an increased risk of obesity in later 
childhood, although the methods used to estimate 
the effect size are open to some criticism. One 
meta-analysis (Horta et al, 2007) reports an odds ratio 
for later obesity according to breastfeeding history, 
stratified into high-income and medium/low income 
countries. Evidence from studies performed in high-
income countries points to a strong association 
between not breastfeeding and adult obesity, with a 
statistically significant odds ratio of 0.77. However, 
many of the data were acquired outside the UK and 
the meta-analysis combined studies that defined 
breastfeeding only as “ever/never” with those that 
measured exact durations of breastfeeding. Caution 
needs to be exercised in interpreting this evidence. 
A further difficulty is identifying the duration of any 
protective effect of breastfeeding. This is important in 
estimating the proportion of obesity cases that might 
be attributed to not breastfeeding as opposed to the 
numerous other contributory factors. For example, 
it might hypothetically be assumed that a protective 
effect of breastfeeding lasts for the duration of 
breastfeeding and a relatively short period afterwards. 
On this basis, breastfeeding might only impact cases 
of obesity that occur before the age of two years. 
To determine the potential cost benefits, it would 
be necessary to calculate both the age of onset 
of obesity and the proportion of obese very young 
children who will be obese adults. This is not possible 
at present. Assuming that the beneficial impact of 
breastfeeding might continue for the rest of the 
child’s life would markedly, and perhaps erroneously, 
overestimate the impact and financial consequences, 
of obesity among those not breastfed. 
Calculating the economic benefits of breastfeeding 
would also require an age-standardised estimate of 
the cost of treating obesity. If a lifetime perspective 
were adopted, recognising that the majority of the 
costs are associated with long-term complications, 
age-adjusted risk ratios for developing weight-related 
conditions over the course of an individual’s life would 
be required. This also would require more data not 
currently available and development of a complex 
simulation model of the type conducted in the 
Foresight report (McPherson et al, 2007). 
Whilst it is unrealistic to make accurate estimates, 
it is possible at least to put the potential costs into 
context. The 2001 UK Census (Office for National 
Statistics, 2002) estimates that there were 3,486,469 
children age less than 4 years. Applying data on 
the rates of obesity from the 4–5 year cohort in 
the National Children’s Measurement Programme 
(Department of Health, 2011) reported above (9.4%), 
suggests that there were 327,728 obese children. 
Studies from the United States have estimated an 
annual incremental health care cost of between 
US$170–300 for obese children compared to children 
of normal weight (Trasande and Chatterjee, 2009). If a 
conservative incremental cost for the UK is assumed, 
based on the above figures, of £100 per child per 
year, this equates to a cost to the health service in 
excess of £32 million per year. 
Horta et al (2007) conclude that breastfeeding may 
offer a “small protective effect on the prevalence 
of obesity.” On this basis, we have assumed that 
increased rates of breastfeeding might offer the 
potential to reduce childhood obesity by 5%, then:
•	 the number of obese young children would fall 
by approximately 16,300, and 
•	 annual health care expenditures would reduce 
by circa £1,630,000 per year.  
These figures are merely illustrative and must be 
interpreted with caution. They take no account of 
the lifetime costs that might result from cost savings 
extending into adulthood. This would increase 
substantially the cost savings that would accrue if 
breastfeeding were more prevalent. Nor do these 
figures capture the broader impacts of obesity, 
including the impact on well-being, life expectancy 
and the economy as a whole. It is difficult to quantify 
these impacts but such broader societal costs need 
to be further studied. 
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4.6 Summary of estimated costs using narrative 
economic analyses
Table 43 summarises the economic impact of the 
conditions where we have conducted narrative 
economic analyses. These figures are illustrative and 
must be interpreted with caution. They are based on 
very conservative estimates, and take no account of 
longer term, lifetime costs of obesity, for example. 
Neither do they capture the broader impact of these 
conditions, which are likely to have an impact on 
well-being, life expectancy, and the economy as 
a whole. Further work is needed to capture these 
important and extensive consequences. 
Table 43: Summary of estimates of economic consequences 
(undiscounted) of not breastfeeding on three conditions: 
cognitive outcomes, SIDS, and early years obesity.
Condition Economic impact
Cognitive outcomes If the proportion of never breastfeed infants were to decrease by only 1%, 
the resultant estimated impact would be around 8,000 fewer children who 
experience cognitive impairment, resulting in about £278 million gains in economic 
productivity – over the lifetime of each annual cohort of children born.
Additional cost savings would accrue from reduction in behavioural problems 
related to not breastfeeding.
SIDS A modest increase in exclusive breastfeeding for more than two months could 
result in avoiding at least three cases of SIDS annually: preventing a monetary 
loss of approximately £4.7 million annually as well as avoiding the profound 
consequences for families.
Early years obesity A modest increase in breastfeeding rates could result in a reduction in childhood 
obesity by circa 5%. If this was the case, the number of obese young children 
would fall by approximately 16,300, and annual health-care expenditures would 
reduce by circa £1.63 million. 
Total estimated cost savings 
from very modest increases in 
breastfeeding
£278 million gains in economic productivity – over the lifetime of each 
annual cohort of children born £6.33 million annual cost savings. 
Total estimated value of QALYs 
gained from avoiding SIDS
£3.8 million annually 
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5 SETTING THE FINDINGS IN CONTEXT
To set the findings of the economic analyses 
presented in Section 4 in context, three further steps 
are needed. This section considers: 
1. The conditions for which limitations of the 
evidence base have precluded meaningful 
quantification of the costs of illness  
2. The funding needed to increase support for 
breastfeeding women in order to achieve 
prevalence comparable to that used in our 
economic models. We will present an illustrative 
case of the costs of implementing these 
changes in one region, to inform local service 
commissioners and planners 
3. The costs to families and society related to 
breastfeeding or not.  
 
5.1 Breadth of diseases not included in our 
economic analyses
Section 4.1.2 lists eight conditions that affect both 
mothers and children and are related to the mode 
of infant feeding (referred to as the ‘long list’). They 
include diseases that severely affect quality of life, and 
ones that persist in adult life, such as coeliac disease, 
diabetes, asthma, and cardiovascular disease. 
The limitations of the evidence base were varied. In 
many studies, infant feeding was not measured or 
reported adequately. In others, only proxy outcomes 
were identified: for example, blood pressure as a 
marker of cardiovascular risk. Nevertheless, it is 
essential that the potential economic implications 
of these diseases are considered; current evidence 
overall suggests that the risk of several of these 
chronic conditions such as cardiovascular disease or 
diabetes, while of complex aetiology, is influenced 
by mode of infant feeding. Whilst the strength of 
the association between breastfeeding and these 
conditions remains uncertain, even a marginal 
reduction in their incidence as a result of changes in 
breastfeeding behaviours could result in considerable 
cost savings. It is likely that broadening the financial 
impact of these conditions on the broader economy  
would demonstrate the scale and scope of the  
 
financial burden of these diseases. Further research 
is nevertheless required to substantiate this 
statement and measure the scale of this impact. 
To illustrate the importance of this research agenda, 
we identified estimates of the economic burden of 
three diseases – diabetes, asthma, and cardiovascular 
disease – on the current health services:
•	 Diabetes  was estimated to cost the 
health service £2.8 billion in 2007 (National 
Collaborating Centre for Chronic Conditions 
and Royal College of Physicians, 2008). Other 
studies have suggested that it may account for 
as much as 7–12% of total health expenditures, 
which equates to close to £10 billion at current 
levels of NHS funding (National Collaborating 
Centre for Chronic Conditions and Royal College 
of Physicians, 2008).  
•	 Costs of cardiovascular disease to the NHS 
have been estimated at around £14 billion per 
annum, with a total cost to the economy in 
excess of £30 billion (BHF) 
•	 Health care costs related to asthma have been 
estimated as being in excess of £2.3 billion per 
annum in 2001 figures (Asthma UK) 
We cannot estimate with any precision the potential 
savings associated with increasing breastfeeding 
prevalence, but even a marginal reduction in 
the incidence of these conditions brought about 
by a change in infant feeding behaviours could 
significantly exceed the financial impacts estimated 
in Section 4. The quantitative economic findings 
we have reported provide only a partial perspective 
on the scale of the costs associated with not 
breastfeeding; they are likely to represent only a 
fraction of the total costs incurred. Addressing the 
economic impacts associated with the chronic 
conditions listed in Section 4.1.2 therefore provides 
an important research agenda. 
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Figure 7 below is an illustrative, diagrammatic 
representation of this, showing that the costs 
presented here are likely to be a small sub-set of 
the real costs of disease and developmental deficit 
due to low rates of breastfeeding. Note that the 
darkening shades represent increasing levels of 
uncertainty about the relationship to breastfeeding 
and therefore the associated costs.
CATEGORY 3
Long list of eight conditions:
ovarian cancer (maternal), diabetes (maternal and child),
asthma, leukaemia, coeliac disease, 
cardiovascular disease, sepsis (affecting child)
CATEGORY 2
Narrative economic
analysis of three conditions:
obesity, cognitive outcomes,
Sudden Infant Death Syndrome (affecting child)
CATEGORY 1
Economic models
of five diseases:
breast cancer (maternal), 
gastrointestinal infection, 
necrotising enterocolitis,
lower respiratory tract infection,
acute otitis media (affecting child),
 
 
8
Figure 7: Diagrammatic representation of the costs 
resulting from disease and developmental deficit resulting 
from low rates of breastfeeding in the UK (illustrative, not 
representative). Conceptually the costs estimated in section 
4 are likely to be a small sub-set of the real NHS costs 
associated with low breastfeeding rates.
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5.2 Costs of increasing breastfeeding prevalence 
In order to increase the prevalence of breastfeeding 
in the UK, it will be necessary both to increase 
the number of women initiating breastfeeding 
and to extend the duration of breastfeeding. Fully 
understanding the net economic impact of increasing 
breastfeeding prevalence requires that potential cost 
savings are balanced against the costs of measures 
to promote, protect and support breastfeeding.
Implementing change to promote breastfeeding 
and support women to breastfeed has been 
recommended for some years in NICE guidance 
(National Institute for Health and Clinical Excellence, 
2008 updated 2011) and in strategy documents 
in Scotland (The Scottish Government, 2011), 
Northern Ireland (Gossrau-Breen et al, 2010), and 
Wales (National Assembly for Wales, 2001). Further 
developing such promotion and support would 
be an appropriate response to the inclusion of 
breastfeeding initiation and duration at 6–8 weeks 
in the Commissioning Outcomes Framework for 
the NHS in England (Department of Health, 2012). 
However, the resources required by the NHS and 
related sectors to achieve such increases have to 
be identified. We recognise that health services 
and public services as a whole are working under 
severe resource constraints, and budgets have little 
or no capacity to respond to additional spending 
requirements. We have therefore considered the 
actions that would be most likely to be both effective 
and efficient in creating the changes needed to 
enable women to breastfeed.
Identifying an effective programme of measures
We sought to identify an appropriate package 
of measures that would tackle the multifaceted 
barriers to breastfeeding, and that could be locally 
commissioned at a time of substantive organisational 
change in the NHS and severe resource constraints. 
We wished to identify a package that would have the 
potential to increase the rates to the levels assumed 
in our policy scenarios; at the least, to support 21% 
of women to breastfeed exclusively at four months, 
for 50% of babies to be breastfed at discharge from 
neonatal units; and for 16% of women to breastfeed 
for 7–18 months in their lifetime. 
First, we considered evidence on effective 
interventions, and national strategies and guidance. 
A series of systematic and critical reviews has 
identified key interventions that are effective in 
raising rates of initiation, duration, and/or exclusivity 
– for example Dyson et al (2008), Dyson et al (2006), 
Renfrew et al (2012). A common and important 
finding has been that overcoming the challenges 
facing women who consider breastfeeding requires 
the implementation not of single interventions, but 
of a multifaceted package of interventions tailored 
to the needs of the local population. These must 
together address the clinical, educational, and 
societal barriers to breastfeeding. This evidence base 
has informed the UNICEF UK Baby Friendly Initiative 
community programme (UNICEF UK Baby Friendly 
Initiative, 2008 revised), NICE guidance (National 
Institute for Health and Clinical Excellence, 2006a; 
National Institute for Health and Clinical Excellence, 
2008 updated 2011), and strategy documents in 
Scotland (The Scottish Government, 2011; Scottish 
Parliament, 2005) and Northern Ireland (Northern 
Ireland Breastfeeding Strategy Group, 1999). Priority 
recommendations common across the four UK 
countries for care offered in hospital and community 
settings include: 
•	 Implementation of a structured programme 
that encourages breastfeeding in NHS Trusts, 
using the UNICEF UK Baby Friendly Initiative 
accreditation as a minimum standard. 
•	 Training of health professionals to protect 
and promote breastfeeding and to support 
breastfeeding women. 
•	 Implementation of a multifaceted programme of 
interventions across different settings, including 
staff training, peer support, and activities to 
raise awareness and overcome barriers to 
breastfeeding; ensuring peer supporters are 
part of a multidisciplinary team and receive 
appropriate training. 
•	 Identification of a health professional with 
responsibility for breastfeeding policy at  
local level.
One locality has agreed a relevant comprehensive 
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programme. Lancashire Children’s Trust have agreed 
and are implementing a region-wide programme for 
commissioning effective, local infant feeding support 
services (Appendix 14). This programme was based 
on key, evidence-based interventions identified 
from the critical and systematic reviews described 
above, and from a national Evidence into Practice 
exercise involving several hundred practitioners and 
user representatives (Dyson et al, 2010b). These 
were further developed in a consultation exercise 
involving academics, health professionals and service 
user representatives, undertaken in 2011 to identify 
the top 10 interventions to promote and support 
breastfeeding in times of severe resource constraints 
(Entwistle et al 2011, Lancashire Children’s Trust: 
Appendix 14). A list of 10 interventions was finally 
agreed following widespread electronic consultation. 
The priorities identified go beyond current national 
priority recommendations. Participants agreed 
that the interventions should be seen as a whole; 
selecting only one or two of the interventions 
was considered likely to be less effective than 
implementing all elements together. Components 
of this programme have since been examined in 
practice (Thomson et al, 2012; Dykes et al, 2011).
We have used the Lancashire programme as a 
basis for illustrating the cost of an evidence-based, 
multifaceted intervention programme at local 
level; we have also produced Lancashire-specific 
versions of our cost of illness models to see how the 
illustrative estimates of costs of interventions and the 
costs of disease compare at the level of one region.
The components of the Lancashire Children’s Trust 
programme are shown in Box 1; those shown in bold 
are currently priority policy recommendations across 
the UK.
Box 1: Components of the Lancashire Children’s Trust programme
1. Maternity services in both the hospital and community setting to gain the World Health 
Organization/UNICEF Baby Friendly Initiative accreditation ‘Ten steps to successful breastfeeding’ 
and the ‘Seven Point Plan for sustaining breastfeeding in the community’.
2. Peer, ‘mother to mother’ support programmes to be implemented alongside health professional 
care.
3. Universities to gain UNICEF UK Baby Friendly Initiative accreditation in pre-registration midwifery 
and post-registration health visiting programmes.
4. Neonatal networks trained to implement effective breastfeeding support for sick and premature babies.
5. Provision of ‘donor’ breastmilk where a mother is unable to breastfeed her baby and including the most 
vulnerable such as premature babies, those in neonatal units and babies age less than 6 months who are 
to be adopted.
6. A robust and critical support service to filter harmful advertising and marketing of formula milks.
7. Strategic leadership, local and regional, to implement evidence-based policy and practice, 
including those areas that impact on infant feeding practice such as where babies sleep.
8. ‘Breastfeeding welcome’ employer, community and public spaces.
9. Schools programmes that promote breastfeeding.
10. Services that support women who are artificially feeding their babies to minimise the risks.
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Primary Care Trusts (PCTs) Initiation of breastfeeding Any breastfeeding at 6–8 weeks
Blackburn 71 36
Blackpool 60 22
Central Lancashire 66 32
East Lancashire 67 39
North Lancashire 68 35
England 83 50
Scotland 74 44
Wales 71 37
N Ireland 64 32
5.3 Illustrative costing of the Lancashire programme
Using information supplied by staff of Lancashire 
Children’s Trust, we have illustrated the costs of the 
implementing this programme across Lancashire, 
in order to demonstrate how it could be adapted by 
other parts of the country (see Table 45 on page 77). 
When considering implementation of a programme 
such as this in other localities, it should be noted 
that costs will vary according to local characteristics; 
factors such as the geographic and population 
base, socio-economic composition, ethnic diversity, 
existing service provision, and current rates of 
breastfeeding may all modify costs.  
5.3.1 Profile of Lancashire region
Lancashire is a region in the north-west of England. 
It includes the 12-district Lancashire County area 
and the two unitary authorities of Blackburn-with-
Darwen and Blackpool, covering over 3,000 square 
kilometres. Lancashire region has a population 
of almost 1.5 million people, with around 13,829 
births annually (13,785 after adjusting for neonatal 
mortality). It is a large geographical area, retaining a 
strong economic base underpinned by long urban 
and industrial traditions. 
Lancashire experiences a greater share of 
deprivation than the national average, and health 
outcomes are relatively poor compared to other 
areas of the country. The social and economic 
diversity evident in the county is reflected in health 
inequalities that persist across local areas. People in 
the most deprived parts of Lancashire experience 
significantly poorer health than those in the most 
affluent parts of both Lancashire and the rest of 
the UK. The 2010 Indices of Deprivation highlight 
a number of local authorities and smaller areas of 
the county that encounter significant problems. 
Six authorities are ranked in the bottom 50 of the 
326 local authorities in England. The percentage of 
the 940 lower super output areas (LSOAs) in the 
14-authority Lancashire area falling into the 10% 
most deprived in the country increased from 16% in 
2007 to 17.4% in 2010. Although Lancashire has a 
lower representation of minority ethnic groups than 
the UK as a whole (91% of the population is classed 
as white British, Irish or other), there are localities in 
the region with higher representation: for example, 
significant Indian, Pakistani and Bangladeshi 
populations are located in Blackburn-with-Darwen 
(20%), Pendle (14%), and Preston (11%). 
Lancashire is a relevant region to act as a model 
for this work, as it has significant challenges of 
deprivation and of geography – with a population that 
lives in both urban and rural areas. Breastfeeding 
prevalence is relatively low (see Table 44), reflecting 
the population base, but there is commitment 
among the public health community to increase the 
breastfeeding rates. 
Table 44: Breastfeeding rates (%) for Lancashire PCTs 2009–10 
(source: DH and ChiMat websites) compared with national 
rates (from Infant Feeding Surveys: Bolling et al, 2007; NHS 
Information Centre, 2011) (Bolling et al, 2007, Information Centre 
for Health and Social Care, 2011)).  
UNICEF UK
Preventing disease and saving resources:  
the potential contribution of increasing breastfeeding rates in the UK80
5.3.2 Assumptions made in the illustrative estimate 
of costs of the programme
The following assumptions have been made to guide 
the costing of the intervention programme:
•	 All costs have been calculated on the basis of 
the Lancashire population and services.  
•	 The perspective of this costing is the 
implementation of policy to promote and protect 
breastfeeding and to support breastfeeding 
women beyond the existing position; assuming 
that the current positive policy position is 
maintained and developed.  
•	 We have assumed that measures identified as 
priorities in national guidance and strategies (as 
described above) have either been implemented 
already, or that plans should be in place. This 
perspective is strengthened by the inclusion 
of breastfeeding initiation and duration at 6–8 
weeks as priorities in the Commissioning 
Outcomes Framework for England (National 
Institute for Health and Clinical Excellence, 
2012). These activities are assumed to be 
already funded or included in future plans and 
are not considered as incremental costs. We 
recognise that some localities have yet to put 
such services in place; while in others, services 
are already embedded in the system. 
•	 Costings have taken into account interaction 
between elements of the programme; for 
example, the infant feeding coordinators and 
strategic leadership identified in point 7 would 
support several specific interventions. The 
programme should therefore be viewed as a 
whole; separating out specific elements would 
require recalculation of the costs.  
•	 We have not included costs to other related 
sectors (for example, education) as part of this 
package. In practice, these costs would be 
shared between different sectors and would not 
accrue to the health service.  
•	 Details of the programme components and the 
calculations of all costs are given in Appendix 15. 
The Baby Friendly Initiative costs are given in 
Appendix 17. 
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 5.3.3 Illustrative estimate of the costs of the 
increasing breastfeeding rates programme  
for Lancashire
Table 45: Total incremental costs of the 10-point programme 
for Lancashire. Activities recommended as NICE priorities 
have not been costed (Full details are given in Appendix 15).
Promotion and support activity Cost Whether any additional cost,  
one-off cost, or recurring
UNICEF Baby Friendly Initiative 
accreditation as minimum standard for 
maternity units and PCTs
Priority national recommendation 
(See Appendix 17 on Baby Friendly 
Initiative costs)
Assumption already in budget 
(Note: Baby Friendly Initiative 
implementation is an ongoing service 
cost - see Appendix 17.)
UNICEF Baby Friendly Initiative 
accreditation of universities
Education of health professionals 
is priority national recommendation 
(See Appendix 17 on Baby Friendly 
Initiative costs)
Assumption already in budget 
(Note: Baby Friendly Initiative 
implementation is an ongoing service 
cost - see Appendix 17.)
Peer support service Priority national recommendation Assumption already in budget.
Neonatal networks training £117,000 One-off
Provision of donor milk £13,300 Recurring
Support service to filter harmful 
advertising
£57,000 Recurring
Strategic leadership £259,000: 50% cost to reflect 
component that is priority national 
recommendation (that is, local 
leadership)
Recurring
Breastfeeding-welcome employers and 
public spaces
Not included in this costing – outside 
of the health sector
Services to support women who are 
formula feeding
Included in current services No additional cost
Schools programme Not included in this costing: outside 
of the health sector
One-off cost: mainly to the  
education sector
Total one-off costs £117,000
Total recurring costs £329,300 
Total Year 1 costs £446,300 
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5.4 Issues to consider
5.4.1 Implementing the programme of change
A multifaceted package is needed to address 
the complex challenges of enabling women to 
breastfeed (Dyson et al, 2006), so it is likely that the 
measures outlined here are complementary and the 
costs are interrelated. Individual activities may be 
less cost-effective if not introduced in a coherent 
programme of planned change; for example, the 
strategic leadership component will support and 
enable most of the other components. 
5.4.2 Further reductions in costs over time
It is possible that as members of staff become 
more skilled, and as newly qualifying students will 
not require additional training, the requirement for 
Trust-based leadership may decrease. Further, the 
number of women experiencing significant problems 
with breastfeeding may decline with increasing 
staff skills, bringing direct savings in the time of 
community and hospital staff and allowing them to 
spend more time on other aspects of care, and also 
directly for the women and their families. However, it 
is also possible that ongoing education and training is 
needed to ensure consistent standards and deal with 
staff turnover.
In the broader context, if more women breastfed, 
and continued to breastfeed for as long as they wish, 
the socio-cultural barriers to breastfeeding would be 
likely to diminish. Increasing awareness and respect 
of protection recently put in place to protect women 
from discrimination when they are breastfeeding 
in a public place (H.M. Government, 2010; Scottish 
Parliament, 2005), together with effective monitoring 
and enforcement of this legislation, is likely to 
improve the situation for many women. 
5.4.3 Considering the costs in context: Lancashire-
specific economic analysis
To set the Lancashire programme costs in context, 
we calculated Lancashire-specific cost of illness 
models, based on the population of the region and 
using Lancashire data where possible.
Table 46 shows the upper, mid and lower estimates 
of potential savings that might be accrued from the 
five disease models. For full details, see Appendix 16. 
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Table 46: Estimated cost savings from Lancashire-specific 
models, for all policy scenarios (see Appendix 16 for details).
Disease or condition Potential cost savings: 
lower estimate 
from least optimistic 
increases in  
breastfeeding rates 
Potential cost savings: 
mid estimate 
from mid-range increas-
es in breastfeeding rates 
Potential cost savings: 
upper estimate
from most optimistic 
increases in  
breastfeeding rates 
Gastroenteritis in infants  
(per year)
£15,341 £89,687 £136,891
Lower respiratory tract infection in 
infants (per year)
£24,898 £145,558 £222,168
AOM in infants (per year) £2,296 £13,425 £20,491
NEC in babies in neonatal units (per 
year)
£40,132 £107,018 £173,904
Total estimated savings from 
costs of treatment of acute dis-
eases in children (per year)
£82,667 £355,688 £553,454
Breast cancer cases avoided of 
annual cohort of 5,504 first-time 
mothers (over lifetime)
11 15 20
Breast cancer treatment costs 
saved of annual cohort of 5,504 
first-time mothers (over lifetime)
£268,982 £371,317 £487,580
Breast cancer: value of QALYs 
saved of annual cohort of 5,504 first 
time mothers (over lifetime)
£130,219 £179,761 £236,046
Breast cancer: incremental 
benefit of annual cohort of  
first-time mothers (over lifetime)
£399,201 £551,078 £723,626
These estimates suggest that using an evidence-
based and proactive policy option likely to increase 
breastfeeding rates is expected to generate savings 
on treatment costs of acute infant diseases of 
between around £83,000 and £550,000 per annum. 
Added to this are the treatment costs of breast 
cancer, which accrue over the lifetime of each 
annual cohort of first-time mothers; these costs 
are estimated to be around £270,000 to £490,000. 
Breast cancer-related QALYs saved have been valued 
at between around £130,000 and £236,000 over the 
lifetime of each annual cohort of first-time mothers.
These costs compare to an initial first year 
investment by the health service of around £446,300 
for additional services, in addition to service provision 
currently recommended as priorities in national 
guidance. Recurring costs would be around £329,300 
annually. A significant proportion of the incremental 
investment in services that is required to promote 
breastfeeding can therefore be offset in the short 
term. However, there are two important points that 
should be taken into account. 
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First, the projected savings relate only to those 
conditions that are considered in our cost of illness 
models, and furthermore relate only to the savings 
to the health service; we have only valued QALYs 
related to breast cancer, not for other conditions 
related to the infant. Further, inclusion of the health 
impacts of breastfeeding on those conditions 
considered in the narrative analyses (SIDS, cognitive 
outcomes and early years obesity) would significantly 
alter this position. We have not included quantitative 
calculations on these as a result of uncertainty 
around the scale of the effect, but it is evident that 
it is likely to be considerable. We have also not 
considered the long list of eight, mainly chronic, 
outcomes where further evidence is needed to 
estimate the scale of the effect of not breastfeeding. 
If breastfeeding were to have even a modest impact 
on these other conditions, the return on investment 
in breastfeeding services would look very favourable 
and would increase year on year. The time taken 
to realise the investment will depend on the rate 
at which breastfeeding initiation, duration and 
exclusivity increase, which in turn will depend both 
on factors in the local population and on the extent 
and quality of services to support breastfeeding 
women. The diseases studied here have shown a 
dose-response effect that means that even a small 
increase is likely to result in some savings.
Second, it is important to recognise that the savings 
resulting from disease reduction are unlikely to be 
short-term cash releasing savings: they may be 
accrued over a period of time (for example, for  
breast cancer). The savings represent reductions 
in resource use. In practice, this could mean 
a mix of, for example, lowered expenditure 
on pharmaceuticals for these conditions, and 
reducing staff time spent caring for people with 
these conditions. These may or may not result in 
cash savings, depending on the choices of local 
commissioners. Commissioners need to recognise 
that incremental investment will be required in 
the short term, but that both cash releasing and 
efficiency gains should be made over time.
In 2007, NICE estimated that it would take 15 years 
before a return on investment would be seen from 
implementing the UNICEF UK Baby Friendly Initiative 
(National Institute for Health and Clinical Excellence, 
2006b). In their calculations, they examined the 
costs saved by reductions in AOM, gastrointestinal 
infection, and asthma for infants. The analyses 
presented in this report suggest that investment in 
breastfeeding is likely to lead to a positive net benefit 
within a shorter period. Our analyses indicate that a 
significant proportion of the incremental investment 
can be offset in the shorter term, suggesting that the 
time required for a positive return on investment is 
likely to be closer to one year than to 15. 
5.5 Broader costs to families and society of not 
breastfeeding; the economic consequences of 
infant feeding policy
Our cost of illness analyses have focused on the 
costs to the health services, but the economic 
consequences of infant feeding policy are also of 
relevance to society and the economy, government 
and the community, the family, the mother, and  
the baby/child (Smith, 1999; Rippeyoung and 
Noonan, 2012); see Appendix 5 for related papers 
and discussion. 
The consequence of the current challenging 
environment for breastfeeding women (Section 1.4) 
is that a policy decision not to promote and support 
breastfeeding is likely to result in continued  
low breastfeeding prevalence and a high incidence 
of breastfeeding problems (such as weight faltering, 
engorgement, and mastitis) that can be prevented 
by provision of skilled support. Wider economic 
considerations might include, for example, the costs 
to society (for example, the environmental costs of 
producing formula, bottles and teats; and flexible 
working conditions versus time off work to care 
for sick children); government and community (for 
example, provision of breastfeeding-friendly public 
spaces versus costs to education sector of cognitive 
deficit); the family (for example, time needed to 
support breastfeeding mother versus costs of 
formula, bottles and teats, time off for caring for sick 
child), the mother herself (for example, less time 
spent feeding baby if she has others to help versus 
more time off work to care for sick child), and the 
baby her/himself. This forms an important research 
agenda for future economic research.
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6 SUMMARY AND DISCUSSION
6.1 Strengths and limitations of the study
In this study, our multidisciplinary research team 
has brought together knowledge and understanding 
of health economics, statistics and epidemiology, 
systematic reviewing, infant feeding, user 
perspectives, the clinical understanding of disease, 
and knowledge of health policy, to examine the 
potential costs to the health service of the current 
high rates of artificial feeding in the UK population. 
The study took place over several stages, each of 
which needed debate and discussion among the 
whole research team. The work was conducted 
using structured and transparent processes, and 
clear criteria. Each outcome was considered 
separately, as the evidence and the scale of impact 
was different for each one. We focused on evidence 
that was relevant to the UK, and we developed 
policy scenarios that we considered to be achievable 
in UK settings to calculate the potential for saving 
costs by increasing the rates of breastfeeding. There 
is evidence from other countries to demonstrate 
that our proposed policy scenarios are realistic and 
achievable. Continuing to increase the duration and 
exclusivity of breastfeeding beyond our proposed 
policy scenarios would result in substantive additional 
gains. 
6.1.1 The evidence base
We identified 25 reviews and UK studies that 
informed detailed economic modelling for 
five outcomes (breast cancer in mothers, and 
gastrointestinal infection , lower respiratory tract 
disease, AOM, and NEC in children) and a narrative 
analysis for three (cognitive outcomes, SIDS, and 
early years obesity). 
We examined not only the epidemiological evidence 
(Section 4.3), but also the biological plausibility 
(Appendix 7) of these eight outcomes being related 
to infant feeding. There is good scientific evidence 
to confirm the likelihood of these conditions being 
directly related to not breastfeeding.
 
We also identified a further long list of eight disease 
outcomes of complex aetiology where there is 
reasonably good evidence that not breastfeeding 
increases their prevalence. Together, these eight 
diseases constitute a significant cost burden for the 
NHS. They include ovarian cancer in the mother, 
and diabetes in the mother and child, and diseases 
in the child including cardiovascular disease and 
asthma. Examining further the economic implications 
of these conditions should inform an important 
research agenda. 
We found that the quality of studies and reviews  
has improved somewhat in recent years. However, 
even the good quality studies we identified had 
significant methodological problems. Problems we 
encountered included:
•	 Randomised controlled trials are very 
challenging in this field, and we were mainly 
reliant on cohort or case-control studies. Many 
of these did not, however, adequately control 
for confounding factors 
•	 Studies used varying definitions of diseases 
•	 The low rates of breastfeeding, and especially 
of exclusive breastfeeding, in the UK and many 
other industrialised countries. Few babies 
and mothers experience prolonged, exclusive 
breastfeeding so that the burden of disease 
associated with not breastfeeding can rarely be 
measured and is probably underestimated 
•	 Importantly, the measurement of exposure (the 
duration and exclusivity of breastfeeding and 
the nature of breastmilk substitutes used) was 
invariably weak. Again, this is most likely to 
underestimate the burden of disease associated 
with not breastfeeding 
•	 There were limited data available on the rates 
and costs of disease related to infant feeding. 
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Robust, systematic, conservative,  
UK-specific approach
To maximise the use of the evidence and to manage 
its limitations, we developed a robust, systematic 
and transparent approach that: 
•	 took account of the limitations of the evidence base 
•	 was tailored to the specific circumstances of 
each disease and condition 
•	 used data relevant to the UK 
•	 was careful not to overestimate or underestimate 
the burden of disease or the costs resulting 
from artificial feeding. To avoid the risk of over 
estimation of costs however, we consistently 
erred on the side of conservative assumptions 
when making methodological decisions 
•	 considered realistic policy options in the light of 
evidence of effectiveness of interventions. 
As a consequence of our approach, it is likely 
that our economic models and narrative analyses 
underestimate the economic consequences 
of not breastfeeding in the UK. Further, we did 
not include calculations of the QALYs related to 
infant diseases. As so many other outcomes 
do not have evidence in the form required for 
economic modelling and we have only included 
costs to the health sector, these estimates 
are likely to be a minimum estimate of the 
economic consequences of the current low 
rates of breastfeeding in the UK. The scale of 
our estimates is broadly in line with the analyses 
conducted by others in developed countries. In 
the USA, for example, it is estimated that US$3.35 
billion in treatment costs could be saved by 
increasing current exclusive breastfeeding rates 
at 6 months to 90% (Bartick & Reinhold, 2010). In 
Australia, others have estimated that AUS$9 million 
in treatment costs could be saved by increasing the 
exclusive breastfeeding rates at 3 months to 80% 
(Drane, 1997). In the Netherlands, it is estimated 
that a saving of €250 per newborn per year could  
be achieved by increasing exclusive breastfeeding 
rates at 6+ months to 100% (Buchner et al, 2008). 
In Italy, the difference in treatment costs between 
‘fully’ breastfed (exclusively or predominantly for  
3 months) and ‘non-fully’ breastfed (complementary 
feeding or no breastfeeding) children is estimated at 
€160 per infant per year (Cattaneo et al, 2006). We 
acknowledge that a meaningful comparison of our 
findings with these studies on the ‘scale’ of such 
savings is not possible, as the reported cost-savings 
in the literature refer to different breastfeeding rates 
and scenarios in different countries, the number 
of health outcomes included in the studies differs 
significantly and the definitions of breastfeeding 
vary. Nevertheless, our report confirms the general 
findings of earlier studies from outside the UK that 
increased breastfeeding is associated with potential 
cost savings for the health sector.
6.2 The costs of disease and developmental deficit 
Our extensive review identified the wide-ranging and 
costly impact of ‘not breastfeeding’  to child and adult 
health in the UK. Diseases and conditions that could 
be prevented at least in part by raising breastfeeding 
rates affect mothers and infants who are in special 
care as well as those who are born healthy at term. 
They also include acute and chronic outcomes that 
affect short, medium- and long-term health and well-
being. Artificial feeding affects public health in many 
different ways, with costs to and implications for 
several different sectors.
Quantitative economic analyses: robust costings
The robust, quantitative economic models, using 
high quality evidence, found that by assuming 
achievable increases in the proportion of women 
breastfeeding, and using our mid-range assumptions 
(45% of women exclusively breastfeeding at four 
months, and 75% of babies breastfed at discharge 
from neonatal units), every year there would  
be approximately: 
•	 3,285 fewer gastrointestinal infection-related 
hospital admissions and 10,637 fewer GP 
consultations, with over £3.6 million saved in 
treatment costs annually
•	 5,916 fewer lower respiratory tract infection-
related hospital admissions and 22,248 fewer 
GP consultations, with around £6.7 million 
saved in treatment costs annually
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•	 21,045 fewer AOM-related GP consultations, 
with over £750,000 saved in treatment  
costs annually 
•	 361 fewer cases of NEC, with over £6 million 
saved in treatment costs annually. 
In total, over £17 million could be gained annually by 
avoiding the costs of treating the four acute diseases 
in infants. 
Increasing breastfeeding prevalence further would 
result in even greater cost savings; the more 
optimistic policy scenarios modelled (65% of women 
exclusively breastfeeding at four months, and 100% 
of babies breastfed at discharge form neonatal units) 
showed potential savings from the four acute infant 
diseases of around £27 million.
In addition, in relation to breast cancer and using 
our mid-range policy scenario (half of mothers who 
currently do not breastfeed were to breastfeed for 
up to 18 months in their lifetime), we calculated that 
the following would be saved over the lifetime of an 
annual cohort of around 313,000 first-time mothers, 
the current number of UK women giving birth to their 
first baby each year: 
•	 865 fewer breast cancer cases 
•	 with cost savings to the health service of over 
£21 million
•	 512 breast cancer-related QALYs would be 
gained, equating to a value of over £10 million
•	 resulting in an incremental benefit over the 
lifetime of each annual cohort of first time 
mothers of over £41 million.
The most optimistic policy scenario modelled for 
breast cancer (32% of women breastfeeding for 
over 18 months in their lifetime) would result in an 
incremental benefit over the lifetime of each annual 
cohort of over £41 million.
Even the most optimistic policy scenarios were set 
at realistic levels, taking into account rates achieved 
in other European countries – for example, Sveriges 
officiella statistik och Socialstyrelsen (2009), Lande et 
al (2003) – as well as the marked increase in initiation 
rates observed in the UK in the past 25 years. 
Greater economic gains would be made were rates 
to exceed these levels. 
6.2.1 Narrative economic analyses: estimates of 
broad magnitude 
Our narrative analyses of three conditions where 
modelling was not possible, and where costs 
reached widely to sectors outside of the health 
service, found that: 
•	 decreasing the never breastfed rate by 1% could 
result in over £278 million gains in economic 
productivity over the lifetime of each annual birth 
cohort from improved cognitive outcomes 
•	 a very modest increase in the rates of exclusive 
breastfeeding could result in the avoidance of at 
least three cases of SIDS annually, preventing  
an annual monetary loss of around £4.7 million 
and a loss of £1.3 million annually in QALYs, as 
well as avoiding the profound consequences  
for families 
•	 increasing breastfeeding rates to a level that 
reduced the rates of early years obesity by as little 
as 5%, would result in reducing annual health 
care expenditures by more than £1.6 million.
The nature of these conditions, and the limitations of 
the current evidence base, mean that the scale and 
scope of the economic impact is difficult to measure 
with precision. It is evident that it is likely to be very 
wide ranging, and very costly, and the work on these 
topics informs an important research agenda.
6.2.2 Other diseases where evidence is needed
We identified a long list of eight further diseases and 
conditions where evidence of an adverse effect of 
not breastfeeding exists, but where the evidence 
did not meet our strict criteria for the cost of illness 
analysis (Table 7). Some of the conditions on this 
long list are among the most expensive to the NHS. 
They include ovarian cancer and Type 2 diabetes 
in the mother, and asthma, cardiovascular disease, 
coeliac disease, leukaemia, sepsis, and diabetes  in 
the child. Reducing these conditions by even 1–2% 
would have a major economic impact. 
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A further 173 systematic reviews or relevant studies 
examining 45 diseases and conditions affecting both 
mothers and children were identified. We considered 
the evidence available to be too limited to comment 
on. Further research on these may help to clarify the 
extent of any relationship with infant feeding. 
Investing in enabling women to breastfeed 
Increasing the prevalence of breastfeeding will need 
investment in services. Using one English region as 
an example, we illustrated the cost of implementing 
a multifaceted, evidence-based regional programme 
that would build on priority national recommendations. 
Within any UK locality of similar size and population 
base, such a programme would cost around £446,300 
in its first year, with a recurring annual cost of around 
£329,300. These costs could be set against our mid-
range estimate of potential short-term cost savings 
per year in this region resulting from the treatment 
costs of the four acute infant diseases of around 
£355,000. There would be further cost savings from 
the treatment of breast cancer, which would accrue 
over the lifetime of each annual cohort of mothers; our 
mid-range estimate of this cost is around £370,000. 
Breast cancer QALYs saved over their lifetime would 
be valued around £180,000. Although quantitative 
calculations for the three conditions examined in our 
narrative analyses cannot be included as a result of 
uncertainty around the scale of the economic impact, 
the cost burden of these conditions would add 
considerably to this scenario. 
Our analyses indicate that a significant proportion 
of the incremental investment in services required 
to promote breastfeeding can therefore be offset in 
the short term, and suggest that the time required 
to show a positive return on investment is likely to 
be closer to one year than the 15 years estimated by 
NICE (2007).
Investing in public health interventions can be seen 
as challenging at a time when funds are scarce. 
However, while potential financial savings accrue 
in the future, this report has also shown that the 
potential savings from breastfeeding support 
are additionally likely to be realised over a much 
shorter time horizon. At a time when health-care 
investments need to show a near-term return on 
investment, this is an important consideration.
It is also important to invest in interventions that have 
been shown to be effective, and not to use resources 
on ineffective or short-term initiatives. Effective 
interventions have been identified in NICE guidance 
(NICE, 2008 updated 2011) and in systematic reviews 
(for example, Dyson et al, 2008; Renfrew et al, 2012; 
Spiby et al, 2009; Beake et al, 2012).
6.3 Wider economic implications
We have considered the potential economic 
implications of not raising the breastfeeding rates 
to the UK economy more broadly. These are likely 
to include adverse impacts at the levels of wider 
society, families, and for women and babies. 
Successive national Infant Feeding Surveys show 
that over 90% of women who stop breastfeeding 
in the first six weeks, and 75% who stop in the 
first nine months, would have liked to breastfeed 
for longer. This indicates that the lack of support for 
women and the lack of protection for breastfeeding 
in society leads to disappointment and distress. 
This disappointment can result in a backlash against 
breastfeeding, and blaming of those who promote 
breastfeeding and work to support breastfeeding 
women. It can promote a contentious discourse 
even among health professionals, academics and 
journalists as well as the wider public (for example, 
Martyn, 2011; Dyson et al, 2010a; Henderson et al, 
2000; Lee, 2007, and so on), and risks perpetuating 
the costs of not breastfeeding to the wider society 
as well as to the health services. Conversely, it 
indicates that women want to breastfeed and want 
to breastfeed  for longer, and that active policy 
support to enable women to breastfeed and to 
prevent problems has the potential to break through 
the inter-generational barriers and entrenched 
patterns of inequality. 
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6.4 Policy environment
Breastfeeding initiation rates in the UK have risen 
steadily over the past decade, from 62% in 2000 
to 81% in 2010. This has been in the context 
of a strong policy environment, nationally and 
internationally, and includes the WHO Global 
Strategy on Infant and Young Child Feeding (WHO, 
2003), and positive policy developments and NHS 
guidance to promote breastfeeding across all four 
countries in the UK (UNICEF UK Baby Friendly 
Initiative, 2001; Department of Health, 2007, National 
Institute for Health and Clinical Excellence, 2008 
updated 2011; Department of Health, 2009; The 
Scottish Government, 2011; Department of Health, 
1995; Northern Ireland Breastfeeding Strategy 
Group, 1999; SACN/RCPCH Expert Group on Growth 
Standards, 2007). 
However, early discontinuation and low rates of 
exclusive breastfeeding persist. Around 40% of 
women stop breastfeeding in the first few weeks 
after birth (Bolling et al, 2007; Child and Maternal 
Health Observatory, 2012). It appears that the UK 
environment does not yet enable women to continue 
to breastfeed, so that choice remains out of reach 
for many women. As a result, women encounter 
not only problems with breastfeeding, but the 
accompanying distress and guilt of not being able 
to continue with their chosen method of feeding 
their babies. This is likely to have an impact on the 
critically important, formative days and weeks of the 
child’s life and the development of the family. Figure 
8 illustrates the linked factors that result from an 
environment in which women are not enabled – with 
full support from all relevant sectors –  to continue to 
breastfeed their baby for as long as they wish. 
Figure 8: The linked factors that exist when women 
are not enabled to breastfeed for as long as they wish, 
resulting in avoidable burden of disease and costs to 
the health service and wider economy. (Derived from 
findings of studies including Dyson et al, 2006.)
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Breastfeeding promotion needs to take place in 
an environment where women are informed and 
supported; and where breastfeeding problems 
can be prevented or, where they do occur, can 
be easily and quickly resolved. This will require 
the implementation of a multifaceted programme 
of interventions. Our findings may reassure 
policymakers, service planners and commissioners 
that such interventions are likely to result in a rapid 
return on investment.
6.5 Research agenda
There is an important research agenda to examine 
further the extent of the public health burden related to 
infant feeding patterns in the UK. This could include: 
•	 Detailed studies examining the complex 
relationships between infant feeding and the 
economic and health consequences of those 
conditions for which we were able only to 
conduct narrative analyses. These were cognitive 
outcomes, SIDS, and early years obesity. 
•	 Further examination of the relative contribution 
of infant feeding to causation of chronic disease. 
We identified a long list of eight conditions of 
multifactorial aetiology where more information 
is needed to quantify the specific contribution of 
infant feeding.
•	 Our systematic literature search identified a 
further 45 conditions for which limited data 
exist. This offers further scope for research.
•	 Long-term prospective cohort studies should be 
established specifically to examine these issues. 
These should adopt accurate measurement of 
exposure to feeding modalities. 
•	 Robust cost-effectiveness analyses are needed 
that compare the costs of interventions, and 
the best mix of interventions, with the potential 
benefits accrued.
•	 Studies of the costs and benefits at a household 
level for varying infant feeding practices would 
inform the economic issues for families.
•	 Research is needed to examine why both 
the public perception of breastfeeding and 
professional discourse is so contentious in the 
UK. Such insight could assist more effective 
promotion of breastfeeding and support for 
breastfeeding women.
•	 Studies of infant feeding require specific 
methodological approaches. In-depth 
discussions of relevant research methods exist 
and should inform future research design (for 
example, Renfrew et al, 2007; Labbok and 
Coffin, 1997).
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7 CONCLUSIONS AND RECOMMENDATIONS 
Enabling women to breastfeed is a health 
issue where the interests of the mother, baby 
and the health services all align. Our extensive 
review has identified the wide-ranging impact of 
not breastfeeding on child and adult health in the 
UK. Artificial feeding affects public health in many 
different ways, with costs to and implications for 
several different sectors.
The inclusion of breastfeeding in the national 
strategies across the UK countries, and most 
recently in the Commissioning Outcomes 
Framework for England (National Institute for Health 
and Clinical Excellence, 2012) is a key opportunity 
to improve population health and to tackle health 
inequalities. However, promotion of breastfeeding 
alone is not enough. Greater investment in support 
for women who have chosen to breastfeed is 
essential. Effective, proactive, accessible, high quality 
services are needed. Such services would minimise 
problems and intervene swiftly and appropriately 
when needed, thereby enabling women to sustain 
breastfeeding, and improving the health of mothers 
and babies. They would save money both for the 
health services and the broader economy, and for 
families. This study should reassure policymakers, 
service planners and commissioners that a rapid 
return on investment is realistic and feasible.
More research is needed to extend our knowledge 
of the impact of infant feeding on health. This 
would improve the modelling and analysis we have 
undertaken, and permit accurate costing of three 
conditions in which we found data insufficient for 
modelling. Our quantitative analyses were limited 
by the lack of adequate data to the examination of 
four acute diseases in infants and breast cancer in 
mothers. We have identified a priority long list of 
eight further conditions where data exist, but not yet 
in a form that permits economic modelling. These 
include several chronic disease outcomes. Our 
inability to model the economic impact of important 
and expensive chronic diseases reflects a failure by 
the health and research communities to resolve the 
long-standing methodological challenges in this field, 
and to acknowledge its potential in reducing future 
health costs and improving population health. This is  
 
a symptom of the core, somewhat circular, problem: 
until adequate data are available, the magnitude of 
the contribution of low breastfeeding rates to chronic 
disease cannot be measured or recognised, so the 
issue remains of low priority. The resultant lack of 
current systemic support for breastfeeding, together 
with the ongoing normalisation of artificial feeding, 
risks perpetuating growing rates of related health 
problems and the costs of treating them at scale. 
There is a need for society to debate infant feeding 
more widely; its economic consequences, and its 
role in child health, child development, maternal 
health, family life and relationships.
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A strong mother-baby relationship is the foundation 
for a baby’s future health and well-being. 
Breastfeeding supports this loving bond and makes a 
vital difference to health.
 
Recognising that the support mothers receive is 
crucial to successful breastfeeding, the World Health 
Organization and UNICEF have a joint, worldwide 
programme – the Baby Friendly Initiative.  
For the past 16 years, UNICEF UK has been running 
the Baby Friendly Initiative in the UK, seeking to 
improve care around infant feeding in the NHS 
and reduce health inequalities. The Baby Friendly 
Initiative is funded through charging for the training 
and tools that we provide. No donor money to 
UNICEF was used to fund this research.
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